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Abstract 
 
Chloride intracellular ion channel 1 (CLIC1) has peculiar properties compared to most 
known ion channels, in that it exists both as a soluble protein and as a membrane-integrated protein. 
Previous studies have shown that CLIC1 insertion into the plasma membrane is driven by different 
stimuli such as oxidation, cytoplasmic acidification, increased calcium concentration. Once inserted 
into the plasma membrane CLIC1 forms a chloride selective ion channel. 
The best characterized mechanism leading CLIC1 into the plasma membrane is cell oxidation. Our 
laboratory has previously shown that in microglia cells stimulation by amyloid beta peptides, one of 
the most common hallmarks of Alzheimer disease (AD), determines the increase of CLIC1-
mediated current.  
Many studies have demonstrated that many AD patients show at first visual impairment 
rather than other cognitive deficits. AD patients show severe abnormalities in the structure and 
function of the retina, including retinal ganglion cells (RGCs) loss. Several cellular mechanisms 
precede RGCs degeneration, including oxidative stress. Therefore, in view of the oxidation-driven 
behavior of CLIC1, during my PhD, I analyzed CLIC1 expression in mouse retina. We found out 
that CLIC1 expression is increased in retinas of two different AD mouse models. Interestingly, 
CLIC1 increased expression is prior to the manifestation of the first cognitive symptoms, thus 
proposing CLIC1 as an early marker of neurodegeneration in AD. 
Although CLIC1 expression is largely increased in AD mouse retinas, CLIC1 is also 
expressed in wild type retinas, mainly in the gangliar layer, where the nuclei of RGCs, whose axons 
make up the optic nerve, are located. Thus, we wondered about the role of CLIC1 in the normal 
RGCs physiology. Our studies unraveled the crucial role of CLIC1-mediated current in axon 
outgrowth of RGCs, showing that the inhibition of the chloride current causes a reduced axon 
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outgrowth that is parallel to an altered morphology of the growth cones and a reduced co-
localization of CLIC1 with the actin cytoskeleton. Our results also suggest that CLIC1 involvement 
in axon outgrowth might be due to CLIC1 modulation by cAMP. Taken together our data propose 
cAMP, or cAMP homologues, as a putative tool to modulate CLIC1 transient expression at the 
plasma membrane and consequently axon outgrowth. 
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Introduction  
 
David Hubel, Nobel prize for Physiology and Medicine in 1991 for his studies on the 
information processing in the visual system, said: 
“The brain is a tissue. It is a complicated, intricately woven tissue, like nothing 
else we know of in the universe, but it is composed of cells, as any tissue is. They 
are, to be sure, highly specialized cells, but they function according to the laws 
that govern any other cells. Their electrical and chemical signals can be detected, 
recorded and interpreted and their chemicals can be identified; the connections 
that constitute the brain’s woven network can be mapped. In short, the brain can 
be studied, just as the kidney can.” 
Thus, although the great and beautiful complexity of the human brain, it is made up by cells, like 
every organ in the body, and it can be studied: its electrical and biochemical signals can be 
interpreted. 
The last decades of the previous century was characterized by a mutual effort to explore the 
brain functioning and was defined as the “brain era”.  Many advances were achieved in the study 
of the physiology and the physiopathology of the brain. However, in spite of all the resources 
and manpower utilized in the neurophysiology research, our comprehension of the brain network 
mechanism remain marginal. 
Since the pioneering studies of Alan Lloyd Hodgkin and Andrew Huxley on the electrical 
properties of excitable cells, our knowledge on the nature of the signals responsible for the 
communication between neuronal cells underwent fast steps ahead, allowing the study of these 
mechanisms at the molecular levels. 
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From the key role of ion channels in determining the bioelectrical properties of excitable 
membranes, to intracellular components and second messengers: it became clear the fascinating 
complexity and variability of the neuronal signals. 
Every day a little piece to the “puzzle” of the brain functioning and neuronal interconnections is 
added by hundreds of experimental works performed all around the world. Each single protein 
has its role. Perfectly integrated in the neuronal networks, each molecule gives its small 
contribution to the complex organized neuronal physiology. 
During my PhD I focused my attention on one of these small molecules, unraveling its own 
contribution to the brain physiology. 
CLIC1 (Chloride Intracellular Ion Channel 1) was the first member identified of a family of 
intracellular chloride channels (Valenzuela et al., 1997). CLIC1 is a polymorphic protein, with a 
double nature as a cytoplasmic protein and as a membrane-inserted protein. It has been shown 
that upon different stimuli, such as increased calcium concentration, acidification, and altered 
redox conditions,  CLIC1 undergoes major structural rearrangements that lead its translocation to 
the plasma membrane. Once inserted into the lipid bilayer, it has been shown to constitute a 
chloride selective ion channel (Averaimo et al., 2010).  
Although since its cloning many biochemical and biophysical studies have been performed in 
order to demonstrate its ion channel identity, its physiological function has been only recently 
demonstrated.  
In resting microglia, CLIC1 is present in its soluble form in the cytoplasm. However, upon 
stimulation with different pro-oxidant compounds, such as phorbol esters, H2O2, LPS, that alter 
the cellular redox state, CLIC1 inserts into the plasma membrane (Milton et al., 2008;Novarino 
et al., 2004). 
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Our laboratory recently demonstrated CLIC1 involvement in neurodegeneration in Alzheimer 
Disease (AD). 
AD is a progressive neurodegenerative disease affecting more than 20% of people worldwide. 
From a medical point of view, it is characterized by memory loss and cognitive impairment, 
caused by a massive neurodegeneration mainly localized in the hippocampus and in the cortex. 
From a histological point of view, it is characterized by intraneuronal accumulation of the 
hyperphosphorilated form of the cytoskeletal protein tau, and deposits of amyloid beta protein in 
the extracellular milieu, surrounded by activated microglia (Zhang et al., 2011). 
Microglia cells represent the immune system of the brain. In case of dangerous insults to the 
brain health, such as bacterial infections, ischemia, or, in AD, amyloid beta peptides, they 
become activated. Activated microglia secretes pro-inflammatory factors such as tumor necrosis 
factor alpha, nitrites, cytokines and reactive oxygen species (ROS) in an attempt to eliminate the 
“insult”. However, these factors are toxic to neurons. While in bacterial infection the damage is 
restricted to specific brain areas, in AD the insult represented by amyloid beta peptides, is 
diffused throughout the brain, and the incapability of microglia cells to completely phagocytose 
and eliminate it, causes a chronic inflammation that leads to a massive neurodegeneration and to 
the typical symptoms of AD (Block et al., 2007).  
NADPH oxidase is the main enzyme responsible for ROS production by microglia cells. Once 
activated, NADPH oxidase catalyses the displacement of electrons from the intracellular donor 
NADPH to the extracellular oxygen, causing the formation of superoxide anion, which is highly 
reactive. The displacement of negative charges carried by electrons leads to a net outflow of 
negative charges that cause a cell depolarization, which in turn impairs the optimal functioning 
of the oxidase itself (Wilkinson and Landreth, 2006). 
6 
 
Our laboratory has recently demonstrated that CLIC1-mediated current provides the counter ion 
necessary to balance the charges lost during ROS production by the oxidase, allowing an optimal 
ROS production (Milton et al., 2008). 
Several clinical studies have demonstrated a tight link between neurodegeneration typical of AD 
and visual deficits. Many patients, indeed, complain visual impairments before the manifestation 
of cognitive symptoms. In these patients, electroretinograms show strong abnormalities due to a 
down regulation of retinal ganglion cells functioning and a thickening of the RGC layer (Berisha 
et al., 2007;Milton et al., 2008). The axons of the RGCs are gathered to form the optic nerve, 
which project to the visual cortex (Wallace, 2011). 
Being unprotected by the skull, the eye represents the most accessible part of the central nervous 
system (CNS). Thus, these observations lead us to investigate the retina as a “mirror” of the 
physiopathological state of the CNS.  
One of the main problems in the treatment of AD is that all the actual known treatments 
intervene when the disease symptoms are already manifested, which means that the patients 
already show clear cognitive impairments. At that point the neurodegenerative process is started 
and irreversible: dead neurons are not replaceable.  
So in the last decade the biomedical research in this field is pointing out to the search for an early 
diagnosis. The possibility of intervening when the neurodegenerative process just started gets the 
possibility of rendering more effective the actual treatments.  
In an attempt to identify a marker of neurodegeneration in AD, during my PhD I focused my 
attention on the retina. 
Several studies have shown that CLIC1 is an ubiquitous protein (Ulmasov et al., 2007). It was 
first identified in the immune system, in particular in macrophages (Valenzuela et al., 1997). 
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Further studies have shown its localization in different areas of the brain, in monocytes, and our 
laboratory has recently shown its presence in tumor cells (Unpublished results).  
During my PhD I demonstrated that CLIC1 is also expressed in the mammalian retina. 
Differently from what we were expecting, CLIC1 is not expressed in the retinal microglia. 
However, it was largely expressed in Muller cells (Mazzanti personal communication), which 
represent the main immune system cells in retina (Bringmann et al., 2006), and our studies 
demonstrated the unexpected strong expression of CLIC1 in retinal ganglion cells (RGCs).  
In order to analyze the possibility of using CLIC1 as a marker of AD, I analyzed CLIC1 
expression and localization in retinal sections from AD mouse models. Our results propose 
CLIC1 as an early marker of the physiopathology of AD.  
Furthermore, the strong expression of CLIC1 both in adult and “young”, developing RGCs 
prompted us to analyze also its role in RGCs physiology. In order to understand the 
physiological function of CLIC1 in RGCs, we interfered with CLIC1-mediated current. We 
found out an involvement of CLIC1 in axon outgrowth, suggesting an involvement of CLIC1 
both in neuronal maturation and degeneration, making us to speculate about a possible link 
between these two functions. 
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Chapter 1 
Chloride intracellular Ion Channel 1. 
 
Chloride intracellular Ion Channel 1 (CLIC1) is the first member identified of a 7 members 
family of intracellular chloride channels named CLIC 1-4, CLIC5A, CLIC5B, p64 and 
parchorin, which have a wide tissue and subcellular distribution in mammalian cells (Berryman 
and Bretscher, 2000;Duncan et al., 1997;Heiss and Poustka, 1997;Landry et al., 1993;Nishizawa 
et al., 2000;Qian et al., 1999;Ulmasov et al., 2007;Valenzuela et al., 1997). CLIC1 was first 
cloned in a macrophage cell line activated by phorbol ester (PMA) (Valenzuela et al., 1997). 
CLIC1 is a polymorphic protein, which can be present either as a soluble protein in the 
cytoplasm or as a membrane-inserted protein. Upon different stimuli, such as increased 
intracellular calcium concentration, pH acidification, and changes in the cellular redox state, it 
undergoes major structural changes and inserts into lipid membranes. Once inserted into the 
plasma membrane CLIC1 forms a chloride selective ion channel (Averaimo et al., 2010). 
 
1.1 Biochemical properties of CLIC1. 
CLIC1 is a small protein composed by 241 aminoacids, with a molecular weight of 27 KDa 
(Valenzuela et al., 1997). The crystal structure of the soluble form of the protein has been 
resolved few years ago by Harrop and colleagues (Harrop et al., 2001). CLIC1 has a reduced 
glutathione (GSH)-binding site in its N-terminal domain, which could render this protein 
sensitive to the oxidative state of the cell. The current hypothesis proposes that, upon oxidation, 
the conformational changes that bring the protein to the plasma membrane cause a detachment of 
the GSH from its binding site and an almost complete rearrangement of the N-terminal domain: 
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the GSH binding site is broken and the exposition of a hydrophobic region causes the interaction 
of CLIC1 with the plasma membrane (Goodchild et al., 2009). 
 
Figure 1. 
Crystal structure of monomeric CLIC1. the C-terminal dmain is shaded in dark grey; the 
putative TM domain is shaded in black and the two flanking residues (Cys 24 and Val 46) 
are indicated. The N-terminal domain is in light grey.  Trp 35, used to demonstrate the 
existence of the TM is also indicated. Adapted from Goodchild et al., Eur Biophys J, 
2009.  
 
The N-terminus and the C-terminus domains are connected by a proline-rich region, in which 
proline 91 has been suggested to have a main role in the changes from the soluble to the 
membrane-inserted form of the protein, due to its change from cis to trans configuration (Harrop 
et al., 2001). Although the crystal structure of the membrane-inserted form has not been solved 
yet, bioinformatic studies have shown that CLIC1 has a single putative transmembrane (TM) 
domain between cysteine 24 and valine 46 (Harrop et al., 2001). Not only this region has the 
length and the hydrophobic characteristics necessary to cross the lipid bilayer, but also digestion 
experiments with proteinase K on a strictly related member of CLIC family, CLIC4, suggest that 
this region is protected by the digestion because is masked by the lipid membrane.  
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The mechanism of CLIC1 insertion into the plasma membrane is still not completely 
understood. According to the model proposed by Littler in 2004, in vitro, upon oxidation, CLIC1 
undergoes structural changes that expose hydrophobic residues which promote the protein 
dimerization, in order to minimize the contact with the aqueous solution. In vivo, the 
hydrophobic region could act as a membrane docking region, promoting CLIC1 insertion into 
the plasma membrane, and protein dimerization could be only successive 
 
Figure 2. 
Current model of CLIC1 insertion into the plasma membrane upon oxidation. The 
oxidation-driven conformational change of CLIC1 monomer leads it either to the 
dimerization or to the interaction with the plasma membrane with the N-terminal domain 
facing the extracellular solution and the cytoplasmic  C-terminal domain. Association of 
2 or 4 CLIC1 protein may lead to the formation of the fully functional ion channel. 
Adapted from Goodichild et al., Eur biophys  J, 2009.  
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Cysteine 24 and 59 seem to be crucial for the transition of the monomeric form to the 
dimeric form, probably due to the formation of a disulfide bridge between these two residues to 
stabilize the dimeric form (Littler et al., 2004). 
Goodchild and colleagues demonstrated that the dimerization is not necessary for the protein 
interaction with the plasma membrane, but the monomer itself can first interact with the lipid 
bilayer, and only successively the oxidation could promote the dimerization and the structural 
changes leading to the insertion of CLIC1 into the plasma membrane and the formation of a 
functional ion channel. However, it is still not clear how CLIC1 can interact with the plasma 
membrane before oxidation if the docking-membrane region is masked as part of the GSH 
binding site (Goodchild et al., 2009). 
Only recently, based on FRET experiments Goodchild and colleagues proposed a new model 
stating that to make up a fully functional ion channel, six or even eight CLIC1 subunits need to 
associate together to constitute  the hydrophilic ionic pathway (Goodchild et al., 2011).  
Once inserted into the plasma membrane CLIC1 exposes its N-terminal domain to the 
extracellular side, while the C-terminus remains on the intracellular side (Milton et al., 
2008;Tonini et al., 2000). 
 
1.2 Biophysical properties of CLIC1 ion channel. 
At the beginning, CLIC1 was identified in transfected cells, mainly in the nucleoplasm and 
in the nuclear membrane (Valenzuela et al., 1997). Later, it has been demonstrated that its 
subcellular localization varies strongly amongst the different cell types. For example, in non-
polarized cells it appears diffused throughout the cytoplasm, while in polarized cells it localizes 
primarily at the apical domain (Ulmasov et al., 2007). 
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Due to the main properties of the protein, such as the unusual 3D structure, the actual identity of 
CLIC1 as an ion channel has been largely debated. It seems indeed unlikely that a protein 
undergoes so large conformational changes to insert into the plasma membrane. Thus, many 
scientist proposed that CLIC1 could work as a regulator of other ion channels resident in the 
plasma membrane. However, several studies with different experimental approaches have been 
performed in order to demonstrate its ion channel identity, either in artificial bilayer, in cell 
expression systems or in endogenously CLIC1 expressing cells (Novarino et al., 2004;Singh and 
Ashley, 2006;Tonini et al., 2000;Tulk et al., 2002;Valenzuela et al., 1997;Valenzuela et al., 
2000;Warton et al., 2002). Purified CLIC1 protein reconstituted in artificial bilayer allowed the 
recording of ion channel openings, with the same biophysical features of those recorded in patch 
clamp on single cells, either in transfected CHO (Chinese Hamster Overy) cells or in microglia 
cells expressing endogenous CLIC1 (Milton et al., 2008;Novarino et al., 2004;Tonini et al., 
2000).  Expression of CLIC1 carrying a tag at the N-terminus of the protein demonstrated that 
CLIC1 not only docks the plasma membrane, but it also spans the lipid bilayer forming the ion 
channel, and the ionic flow can be inhibited by antibodies specifically directed against the N-
terminus of the protein (Tonini et al., 2000). CLIC1 ion selectivity has been measured by several 
groups, being I- > SCN- > Cl- > NO32- >Br- > F- (Singh and Ashley, 2006). The reversal potential 
of the current varies accordingly to the changes in chloride concentration (Novarino et al., 2004). 
The single channel conductance of CLIC1 is strictly dependent on chloride concentration. In 
equimolar 140 mM chloride CLIC1 conductance is 30 pS, while in patch clamp experiments, 
where intracellular chloride concentration is 20 mM and the extracellular concentration is 140 
mM, the single channel conductance is 7 pS. CLIC1 is slightly voltage dependent and slightly 
inwardly rectifying (Novarino et al., 2004). 
The only effective ion channel inhibitor so far identified is IAA94, which seems to be quite 
specific at a concentration of 50 µM, with an EC50 of 8.6 µM (Tulk et al., 2002). A 
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crystallographic study demonstrated that the structure of IAA94 is very similar to the ethachrinic 
acid, the inhibitor of the GST protein family (Cromer et al., 2002). The current hypothesis is that 
upon oxidation, CLIC1 loses the GSH and rearranges its structure. After the spanning of CLIC1 
through the plasma membrane the binding site is faced on the extracellular side, accessible to the 
channel blocker (Harrop et al., 2001;Littler et al., 2004).  
Exogenous expression of wild type (WT) and mutated protein in cell systems allowed to record 
CLIC1 single channel activity on the plasma membrane of transfected cells (Milton et al., 
2008;Novarino et al., 2004;Tonini et al., 2000). We have previously shown that point mutations 
of two residues in the putative TM domain significantly alter the biophysical features of the ion 
channel, like the open probability and the single channel conductance, further demonstrating that 
CLIC1 is actually an ion channel (Unpublished results).  
 
1.3 Physiological role of CLIC1 in microglia cells. 
Although many laboratories are actively working to analyze the biochemical and biophysical 
properties of CLIC1, its physiological role has been only recently demonstrated. 
The tight regulation of CLIC1 by redox conditions (Singh and Ashley, 2006;Tulk et al., 
2002;Warton et al., 2002) led to investigate its role in oxidative cellular processes. 
Many cellular processes involve changes in the redox state of the cell, such as duplication, 
migration, differentiation and maturation. Reactive oxygen species (ROS), indeed, may act as 
second messengers. Many proteins have redox-activated sites, containing cysteine residues that 
are modified by changes in the redox state (Menon and Goswami, 2007). Cell homeostatic 
systems stabilize a precise balance between ROS produced and eliminated. 
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Figure 3. 
A) Single channel recordings of CLIC1 in tip dip at the different voltages applied (left) 
and relative iV relationship (right). B) outside out single channel block by IAA94 in BV2 
cells. C) Unpermeabilized stimulated BV2 cell probed with anti NH2 antibody confirmed 
CLIC1 localization in the plasma membrane, exposing the NH2-terminus on the 
extracellular side. D) CLIC1 mediated current recorde din patch clamp on BV2 cell 
stimulated with Ab is specifically reduced by the perfusion of NH2-antibody. E) iV curves 
of CLIC1 mediated current in a BV2 cell (∆) and in primary microglia (■).  F) linear fit 
of  single channel recordings obtained at the different voltages at 149.5 (∆), 60 (ο) and 
30 (•) mM chloride in the cell-attached pipette. Adapted from Milton et al., the Journal of 
Neuroscience, 2008;Novarino et al., the Journal of neuroscience 2004; Averaimo et al., 
FEBS letters, 2010.   
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However, when, for any reason, ROS production overwhelms its removal, a condition of 
oxidative stress is established. Several pathological conditions are characterized by deep 
alterations of the cellular redox state (Behrend et al., 2003;Boillee and Cleveland, 2008;Gao et 
al., 2003;Thomas et al., 2007;Wu, 2006). 
 
 
Figure 4. 
Single-channel current traces are shown for wild type (A and E), R29A mutant (B), and 
K37A mutant (F) transfected cells.  On the bottom of the figure: single-channel iV 
relationship for R29A (C) and K37A (G) and open probability of R29A (D) and K37A (H) 
mutant, compared to the control.  
 
A pathological condition associated with oxidative stress is Alzheimer Disease (AD). 
Activated microglia surrounding deposits of amyloid beta (Aβ) protein in the central nervous 
system, one of the main hallmarks of AD, secretes several neurotoxic factors, including ROS, in 
order to eliminate the dangerous cue. CLIC1 plays a crucial role in ROS production by activated 
microglia (Meyer-Luehmann et al., 2008). 
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ROS production in microglia cells is mainly due to the activation of the NADPH oxidase 
(Bedard and Krause, 2007). The enzyme catalyzes the displacement of electrons from the 
intracellular donor NADPH to the extracellular oxygen (Wilkinson and Landreth, 2006). The 
outflow of negative charges carried by electrons causes a cell depolarization (Decoursey et al., 
2003;Henderson et al., 1987). The excessive depolarization could in turn impair the functioning 
of the oxidase itself, weakening an efficient ROS production (Decoursey et al., 2003). Indeed, it 
has been demonstrated that in other phagocytic cells NADPH oxidase activity starts to decline 
already around 0 mV and it completely shuts down when the membrane potential reaches 200 
mV (Decoursey, 2003). So the cell needs a mechanism to balance this leak of negative charges 
and set the membrane potential to voltages that allow an optimal functioning of the NADPH 
oxidase and an optimal ROS production. Many ionic currents have been proposed to be involved 
and set the membrane potential, such as potassium channels (Reeves et al., 2002), swelling-
activated chloride channels (Moreland et al., 2006), and proton channels (Decoursey, 
2003;Decoursey and Ligeti, 2005;Eder and Decoursey, 2001;Ramsey et al., 2009). Many studies 
performed in neutrophils and eosinophils stimulated by PMA proposed proton current as the 
main responsible for this balancing (Decoursey et al., 2003;Decoursey and Ligeti, 2005;Eder and 
Decoursey, 2001;Ramsey et al., 2009). In symmetrical pH proton current has an activation 
threshold around +40 mV (Eder and Decoursey, 2001). When the cells are activated the 
depolarization reaches levels sufficient to activate proton current and thus counteract the inward 
current mediated by the oxidase. Moreover, knock out cells for the proton channel Hv1 show a 
reduced ROS production (Ramsey et al., 2009). 
The situation is a little different in microglia cells. Once activated by Aβ, microglia cells undergo 
a depolarization, due to the activation of the NADPH oxidase. However, in physiological 
conditions, the membrane potential never reaches positive potentials (Milton et al., 2008). This 
can be possibly due to the much more hyperpolarized resting potential of microglia cells 
17 
 
compared to neutrophils and eosinophils, being on average around -70 mV (Milton et al., 
2008;Novarino et al., 2004;Schilling and Eder, 2007). Upon Aβ stimulation membrane potential 
rarely goes over -40 mV. Therefore, it seems unlikely that in these cells proton channels can be 
activated and able to counteract the NADPH oxidase functioning.  
Chloride ions are the main ions available to counteract the charge movement across the cell 
membrane at the membrane voltage values reached after oxidase activation.  
 
Figure 5 
A) CLIC1 translocation from the cytoplasm to the plasma membrane in Ab-stimulated 
BV2 cell. B) Patch clamp recording on the top, and ROS production on the bottom, 
showing the inhibitory effect of IAA94 on Ab elicited current and the concomitant 
reduction of ROS production in primary microglia. C) Reduced ROS production in Ab-
stimulated primary microglia cells transfected with siRNA against CLIC1, compared to 
control cells. D) Reduced CLIC1 mediated current in siRNA transfected cells fails to 
induce a DIDS-sensitive current upon Ab stimulation. Adapted from Averaimo et al., 
FEBS letters, 2010; Milton et al., the journal of Neuroscience 2008.  
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Indeed, our laboratory has previously shown that the membrane depolarization prompted by Aβ 
stimulation is exacerbated by the inhibition of CLIC1-mediated current with IAA94, by 
eliminating the main counter ion. ROS production is also reduced by knocking down CLIC1 
expression with specific siRNA (Milton et al., 2008). Thus, CLIC1 role seems to be crucial in 
microglia activation during Aβ stimulation. Aβ stimulation of microglia cells at first causes an 
oxidative peak by activating the NADPH oxidase. This unbalanced oxidation causes the 
migration of CLIC1 from the cytoplasm to the plasma membrane. Then, CLIC1 mediates a 
chloride current that, through the inflow of negative charges brought by chloride ions, 
counteracts the ones lost by the displacement of electrons from the NADPH to extracellular 
oxygen. In this way, excessive membrane depolarization is avoided and the oxidase is able to 
work efficiently and produce ROS as a brain defense mechanism (Milton et al., 2008). Changes 
in pH can be easily counteracted by cellular buffering systems (De et al., 2008). However, the 
initial acidification could contribute, together with the oxidation, leading CLIC1 to the plasma 
membrane (Tulk et al., 2002;Warton et al., 2002). Finally, the importance of chloride contribute 
over proton’s in microglia activation in AD is strengthened by the observation that amyloid 
plaques in AD brain are rich in zinc (Oddo et al., 2006), which is one of the well known 
inhibitors of proton current that act by shifting the activation threshold of proton current towards 
more positive potentials (Eder and Decoursey, 2001). Thus, if microglia cells surrounding 
amyloid plaques are in contact with inhibitors of proton channels, is unlikely that they could 
contribute in setting the membrane potential like they do in neutrophils, leaving this issue to the 
main ion available at those membrane potentials: chloride. CLIC1-mediated current is promptly 
followed by a DIDS-sensitive component, which is activated only after IAA94 sensitive current, 
suggesting a trigger role of CLIC1-mediated current versus the DIDS-sensitive current (Milton et 
al., 2008;Novarino et al., 2004). Previous studies have demonstrated, indeed, a role of increased 
intracellular chloride concentrations in modulating other chloride channels (Jentsch et al., 2002). 
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DIDS-sensitive current could then contribute to set the membrane potential together with 
CLIC1-mediated current. 
Mounting evidence suggest an interaction of the members of the CLIC family with the actin 
cytoskeleton. CLIC5 is enriched in actin-containing fractions of the placental microvilli, and 
many studies performed in artificial bilayer showed the inhibitory effect of F-actin on the ion 
channel activity of CLIC1. Indeed, the addition of F-actin from the “intracellular” side causes an 
almost complete inhibition of ion channel activity, while the addition of depolimerizing agents 
like Latrunculin or Cytochalasin leads to a complete recovery (Berryman et al., 2004;Singh et 
al., 2007;Suginta et al., 2001). 
Thus, CLIC1 is a protein with the unique feature of being transiently expressed on the plasma 
membrane, being accessible from the outside and thus an easier target for eventual drug 
treatments. It works as a sensor of cell oxidation, and as an executor itself. However, differently 
from other ion channels resident in membrane and part of the normal cell physiology, CLIC1 is 
functionally expressed only in “stress” conditions. Therefore, CLIC1 might be a perfect tool to 
control specific cell mechanisms. 
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Chapter 2 
Alzheimer’s disease. 
 
One of the largest apprehensions of contemporary life is population aging. During the last 
century the great advances in medical sciences and the healthier living conditions have led to an 
increased life expectancy. As a consequence, medical problems linked to aging have become 
very common. In this scenario, neurodegenerative disorders play a crucial role for their social 
impact.  
Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. It is a 
progressive neurodegenerative disease that causes a cognitive decline, with deep alterations of 
behavior and personality that end up in dementia (Gotz and Ittner, 2008;Zhang et al., 2011). 
 
Figure 1. 
On th eleft panel  oblique coronal  MR image throughout the temporal lobe of a 75-year 
old female control subject, while on the right from a 73-year old female AD patient. 
Adapted from  Jack et al., Neurology 1997. 
 
AD was first diagnosed by the german neuropathologist Alois Alzheimer in the beginning of the 
20th century. In 1901 Alzheimer observed the first symptoms of what was later called 
“dementia”: strange behavioral symptoms, including short-term memory loss. When in 1906 the 
patient died, dr Alzheimer used staining techniques to identify amyloid plaques and 
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neurofibrillary tangles in his brain. The amyloid plaques were positive to the congo red staining. 
In 1906 he presented for the first time the neuropathological analysis of this neurodegenerative 
disorder (Puchtler and Sweat, 1966).   
From the clinical point of view AD is characterized by cognitive deficit and memory loss, due to 
neurodegeneration mainly localized in the hippocampus and in the cortex. From the histological 
point of view, the main hallmark of AD are intraneuronal accumulation of the cytoskeletal 
protein tau, and deposits of amyloid beta (Aβ) protein in the extracellular milieu, called senile 
plaques. The senile plaques are surrounded by activated microglia (Gotz and Ittner, 2008). 
 
 
Figure 2.  
Extracellular aggregation of amyloid beta protein into senile plaques (arrows) and 
neurofibrillary tangles (arrowhead), typical hallmarks of Alzheimer disease.  Adapted 
from Taylor et al., Science 2002.  
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2.1 Amyloid beta. 
Aβ protein is a 42 aminoacid peptide, belonging to the Amyloid Precursor Protein (APP) which 
is a transmembrane (TM)  glycoprotein. APP is synthesized in the endoplasmic reticulum and 
then transported throught the Golgi apparatus and the trans-Golgi-network to the cell surface. 
APP physiological function is still obscure, although it has been proposed a role as a receptor, 
and many evidences link APP to cell adhesion. APP can be alternatively cleaved in an 
amyloidogenic pathway and in a non-amyloidogenic pathway, by α or β secretases respectively, 
and successively by γ secretases. 
α secretases, acting from the outside, cut the extracellular part of the protein giving rise to a TM 
fragment, and the sAPPα. The latter is soluble and has been demonstrated to have several 
neuroprotective properties. The cleavage by α secretase precludes the generation of Aβ, as the 
cleavage site is within the Aβ domain. 
In the amiloidogenic pathway, APP is first cleaved by β secretases and successively by γ 
secretases. BACE1 (beta-site APP-cleaving enzyme) and BACE2 are two beta secretases so far 
identified, although BACE1 is the major β secretase and its expression in neurons is higher 
compared to BACE2. ΒΑCΕ1 is a membrane-bound aspartyl protease. Its expression is found 
increased in the temporal cortex of AD brains. Mounting evidence show that BACE is a stress-
induced protease. Its expression, indeed, is increased in cells exposed to oxidative stress 
(Tamagno et al., 2002) and in in vivo models of cerebral ischemia (Wen et al., 2004) and 
traumatic brain injury (Blasko et al., 2004). BACE1 has been proposed as a putative therapeutic 
target in AD by several studies. Indeed, BACE1 knock out mice do not generate detectable levels 
of Aβ, showing no severe phenotypic abnormalities. Moreover, BACE1 deficiency in AD mice 
is able to rescue neuronal loss and reduce Aβ levels (Luo et al., 2001;Ohno et al., 2007;Tesco et 
al., 2007). Thus, for instance, regulation of BACE1 levels and its β secretase activity through a 
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mechanism specifically involving the small BACE1-interacting protein GGA3 may be the cause 
of increased BACE and subsequently Aβ levels in AD brain (Tesco et al., 2007), proposing 
GGA3 as a possible target in AD treatment. 
 
 
Figure 3.  
Schematic representation of the amyloidogenic and non-amyloidogenic cleavage pathway  
of amyloid precursor protein (APP) by the different secretases. Adapted from Chow et al., 
Neuromolecular medicine 2010.  
 
The fragments belonging either from the cleavage of APP by β or α secretases are the target of γ 
secretase action. The sequential cleavages by α and γ secretases result in a non toxic fragment. 
On the other hand, the cleavage of APP by β and γ secretases gives rise to two main isoforms: 
Aβ 1-40 and Aβ 1-42, the latter being more toxic than the first one. The hydrophobic nature of 
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these peptides leads to abnormal aggregation of these fragments in unsoluble structures known as 
senile plaques (Ling et al., 2003;Zhang et al., 2011). 
The familiar form of AD, which accounts for less than 1% of the total number of AD cases, has 
been associated with mutation in three genes: the gene coding for the APP, presenilin 1 (PSEN1) 
and presenilin 2 (PSEN2). Presenilins are membrane component of the γ secretase complex. In 
sporadic AD different “susceptibility genes” have been identified, including Apolipoprotein E 
(APOE). Mutations in the APP gene are associated with an increased production of Aβ, resulting 
in a major probability of developing the pathology. The APP gene localizes on the chromosome 
21. In individuals affected by down syndrome (trisomy of chromosome 21) there is a major 
probability of developing AD, due to the higher amount of APP expressed (Liang et al., 2008).  
Recent studies correlate the mechanisms of Aβ degradation with increased levels of Aβ in the 
brain. ApoE is involved in Aβ degradation, by positively modulating Neprylisin and Insulin 
Degrading Enzyme (IDE), both responsible for the Aβ deposits removal respectively in the 
extracellular and intracellular environment. Mutations in the gene coding for ApoE, indeed, 
correlate with increased number and size of amyloid plaques in the brain (Ling et al., 2003). 
The action mechanism underlying Aβ toxicity is not completely understood. Many studies 
suggest that Aβ could insert into neuronal lipid membranes forming non selective pores that 
mediate calcium inflow. The resultant increase of intracellular calcium could activate the 
apoptotic pathway, starting with an initial synapse loss, followed by the loss of dendritic spines, 
in the end leading to cell degeneration (Green and LaFerla, 2008). However, several studies 
suggest that the specific interaction of Aβ with AMPA, NMDA and metabotropic glutamate 
receptors expressed on the neuronal surface can be responsible of impaired synaptic transmission 
and in the end leading to neuronal death (Gasparini and Dityatev, 2008).  
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According to the “classical” model, amyloid plaques are the main responsible for 
neurodegeneration in AD. However, more recent studies suggest that soluble oligomers and 
protofibrils may be more dangerous. Indeed, not always the neurodegeneration correlates with 
the presence of senile plaques, but neuronal loss is often localized in brain regions far away from 
amyloid plaques (Dahlgren et al., 2002). On the other hand, oligomers interfere with signal 
transduction in long term potentiation  (LTP), leading to memory impairment typical of the first 
stages of the disease. Protofibrils cause oxidative stress and rapid changes of the 
electrophysiological properties of the neuronal plasma membrane (Chen et al., 2000;Soderling 
and Derkach, 2000). 
 
 2.2 Microglia role in Alzheimer disease. 
Aβ deposits are surrounded by activated microglia and recent studies strongly support the 
hypothesis of a neurodegenerative process mainly due to a microglial hyper-activation caused by 
the spread presence of Aβ in the central nervous system (CNS). Microglia cells represent the 
brain immune system. They represent 12% of the cells in the brain and their density varies by 
brain regions: they are mostly present in the gray matter, with the higher concentrations in the 
hippocampus, substantia nigra, olfactory telencephalon and the basal ganglia. Microglia is 
generally present in a resting state with a typical ramified morphology, with long extensions 
monitoring the brain. However, upon activation by different cues, such as bacteria or damaged 
neurons after brain ischemia, they readily become activated. They undergo main morphological 
changes becoming amoeboid. They express different surface molecules including the major 
histocompatibility complex (MHC), duplicate, migrate towards the site of injury and start 
secreting several substances, such as chemokines, cytokines, nitrites, reactive oxygen species 
(ROS), nitrites, Tumor Necrosis Factor (TNF) α, in order to recall other microglia cells and 
eliminate dangerous cues through phagocytosis (Block et al., 2007).  
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In AD, the incapability of microglia to efficiently remove the senile plaques, which represent the 
“insult”, leads to a chronic microglia activation. The chronic and diffuse inflammation causes a 
massive neurodegeneration, determining the typical symptoms of the disease (Meyer-Luehmann 
et al., 2008). 
 
 
Figure 4. 
PET (positron emission tomography) imaging showing microglial activation in 74 years 
old healthy subject (left) and 65 years old AD patient. Microglia activation was 
visualized taking advantage of the uptake of a radiolabeled ligand usually taken up by a 
benzodiazepine receptor overexpressed in activated microglia. The binding potential is 
an esteem of microglia activation, that is widespread in the patient whereas is negligible 
in the healthy subject.   
 
ROS production in microglia cells is mainly due to the activation of the NADPH oxidase. 
The NADPH oxidase isoform expressed by the phagocytic cells, including microglia, is NOX2. 
The NADPH oxidase is a multimeric enzyme, made up by two transmembrane (TM) subunits: 
gp91phox, which is the catalytic subunit (named NOX2 in phagocytic cells), and p22phox. It is 
also composed by four cytoplasmic regulatory subunits: p47, p67, p40 and Rac-GTP. These last 
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four components associate with the cell membrane only upon different stimuli, such as the 
enhancement of  internal calcium concentration, phosphorylation by protein kinase C (PKC) and 
temperature changes. Once assembled, they constitute the functional protein complex that 
produces superoxide anion, which is released extracellularly during the microglial immune 
reaction. 
 
Figure 5. 
Schematic representation of the constituent subunits of the NADPH oxidase. In resting 
conditions (on the left) and upon activating stimuli (on the right). Adapted from 
Wilikinson and Landreth, Journal of neuroinflammation. 2006.  
 
gp91phox is a highly glycosilated TM protein. The N-terminal domain is made up by six α 
helices; the third one and the fifth one coordinate the heme group. At the C-terminal domain 
there is the binding sites for FAD and NADPH. So, gp91phox contains the whole redox 
machinery that displaces the electrons from the NADPH, through FAD and the two heme 
domains, to the extracellular side. The protein complex constituted by gp91 and p22 represents 
the flavocytochrome b558.  In resting conditions, the proline-rich region at the C-terminus of 
gp91 interacts with the SH3 domain of  p47, avoiding the binding between p22 and gp91, and 
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thus the subsequent enzyme activation. The interaction amongst all the subunits is necessary for 
the functioning of the oxidase, because the interaction of the activation domain of p67phox with 
a region of the flavocytochrome b558 allows the displacement of electrons from the NADPH to 
FAD. p22 is a TM protein with a C-terminal tail rich in prolines that acts as an anchoring site for 
p47. Upon phosphorylation of p47 at multiple serine residues by PKC, the protein undergoes 
conformational changes of the inhibitory domain that allow the interaction of p22 and gp91. 
Then, the C-terminal domain of p47 interacts with the C-terminus of p67, bringing it to the 
plasma membrane. p67 binds to Rac. In resting conditions Rac forms a heterodimeric complex 
with the inhibitor protein RhoGDI in the cytoplasm. Upon stimuli, Rac is released from the 
complex, brought to the plasma membrane and converted into its active form, binding GTP 
instead of GDP. Rac-GDP conversion to Rac-GTP is due to the action of GEFs (guanine-
nucleotide exchange factors) proteins. The interaction of the active form of Rac with the amino 
terminal domain of p67 is crucial for the activation of gp91. Indeed, p67, activated by the 
binding of Rac, directly interacts with gp91, allowing ROS production. Finally, p40 also 
positively regulates gp91 activation, by associating with p67, without affecting p47 interaction 
(Lambeth, 2004;Sumimoto, 2005;Wilkinson and Landreth, 2006).   
The role of microglia in the brain is thus crucial for the CNS health. However, when microglia 
results to be hyper-activated, for example around Aβ deposits, the continue secretion of these 
neurotoxic factors in the end results in vascular damage, neuronal damage and 
neurodegeneration (Block et al., 2007).  
Thus, defining microglia cells as beneficial or detrimental for neuronal survival is not a trivial 
issue. Microglia is important in bacterial infections, or in ischemia, but it becomes a great enemy 
in AD. The key point is likely to be the over-activation of microglia cells.  
Although AD was the first pathology to be linked to microglia over-activation, a chronic 
inflammation state has now been shown to be involved in many other neurodegenerative 
29 
 
disorders, such as Parkinson disease, amyotrophic lateral sclerosis, multiple sclerosis, 
Huntington disease (Behrend et al., 2003;Boillee and Cleveland, 2008;Gao et al., 2003;Thomas 
et al., 2007;Wu, 2006). Microglia activation not only exacerbates ongoing neurodegeneration, 
but it also can cause neurodegeneration by itself (Block et al., 2007).  
 
2.3 Tau protein in Alzheimer disease. 
The key role of Tau protein in AD has been fully demonstrated. AD is indeed also referred to as 
a tauopathy, being also characterized, as we mentioned before, by the aggregation of abnormally 
phosphorilated Tau protein (Grundke-Iqbal et al., 1986). Tau is a microtubules-associated 
protein.  
  
Figure 6. 
Schematic representation of tau involvement in the stabilization of microtubules  and the 
consequence of its detachement from microtubules after hyperphosphorylation in 
pathological conditions.  
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Its primary role, by interacting with microtubules, is to stabilize the neuronal cytoskeleton. It is 
coded by a gene located on chromosome 17 and it undergoes alternative splicing. Alternative 
splicing generates six isoforms. Tau undergoes phosphorylation at different serines and 
threonines, and  phosphorylation decreases the affinity of Tau for microtubules, by preventing its 
binding and destabilizing neuronal cytoskeleton. Cytoskeleton destabilization causes the 
disruption of many cellular functions, including axonal growth, vesicle and organelle transport, 
nervous signal propagation. Tau hyperphosphorylation results from an unbalance between the 
action of phosphatases and kinases: the inhibition of phosphatase PP2A, which has been shown 
to be decreased by 50% in AD brains, or the over activation of the kinase GSK3β.  
Although Tau undergoes many different post translational modifications, such as glycosilation, 
glycation, prolyl-isomerization, nitration, polyamination; phosphorylation is the most commonly 
described. In AD, Tau hyperphosphorilation causes its detachment from the microtubules and its 
oligomerization in strucutres named neurofibrillary tangles, which strongly impair synaptic 
function. Exogenous expression of pseudo hyperphosphorylated Tau mimics structural and 
functional abnormalities typical of AD. However, Tau hyperphosphorylation seems to be 
required but not sufficient per se to induce aggregation, suggesting that other post translational 
modifications may be required (Martin et al., 2011). 
 
2.4 Actual approaches in the treatment of AD. 
Unfortunately until now effective treatments for AD are still missing. Indeed, the actual known 
treatments mainly aim to a stabilization of the patient’s conditions, but they are not able to revert 
the disease progression. 
Indeed, in neurodegenerative diseases the symptoms are manifest only when the 
neurodegeneration is largely diffused, and dead neurons cannot be replaced. Over the last 
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decades many risk factors for neurodegenerative diseases have been identified. However, 
laboratory biomarkers are important to specifically confirm a diagnosis and guide an appropriate 
medical therapy. So far, the combination of Tau and Aβ levels in the cerebro-spinal fluid (CSF) 
gave a good predictive value, better than the two individual biomarkers. However, although 
these results are promising, it is clear that this “strategy” needs to be optimized to be used as a 
screening for a specific treatment. For example, many studies report an increase of Tau levels in 
the CSF, and a decrease of Aβ in the CSF of AD patients. The decreased Aβ presence in the CSF 
has been explained as a consequence of a major accumulation of Aβ in the brain. If this is really 
the explanation to this phenomenon, it means that when AD is diagnosed by Aβ and Tau levels 
in the CSF, the disease is already in a very advanced stage.  
Moreover, magnetic resonance imaging (MRI) and positron emission tomography (PET) 
imaging with amyloid ligands (such as PIB: Pittsburgh compound B), are now largely used in 
clinics. MRI measurements of hippocampal atrophy are also widely used, although they can only 
diagnose a disease already strongly manifested (Mattsson, 2011). 
In the last decade the scientific community is pointing on vaccines for the treatment of AD. 
Using the immune system to attack one of the body’s protein, Aβ, could seem a little risky 
approach, but also very clever and intriguing. The first vaccine, directed against Aβ 1-42, which 
is the Aβ isoform most prone to aggregation, seemed successful in mice, where it dissolved 
amyloid plaques and inhibited formation of new ones, but the trial in humans had bad outcomes, 
causing often meningoencephalitis (a severe brain inflammation). A new approach seemed to be 
more successful. It was based on the intravenous injection of anti-Aβ antibodies to AD patients. 
The levels of these antibodies are indeed lower in AD patients compared to healthy subjects of 
the same age. The results were surprisingly very good, with improvement of cognitive scores and 
a stabilization for all the treatment duration. Although these studies seem really encouraging and 
a large scale trial will be performed before the end of 2012, it encountered against some 
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problems due to the high cost of the treatment, and to the availability of these antibodies, whose 
production capacity by blood of the donors is limited. Moreover, unexpectedly, while the 
treatment was successful in some patients, it almost caused a worsening in patients who started 
the treatment later in the disease course (Schnabel, 2011). Thus, the possibility of diagnosing the 
disease in the early phases of the neurodegenerative process would give the possibility of 
interfering with the disease progression before the damage is so diffused. This would give the 
possibility of a more effective treatment.  
 
2.5 Retina as a mirror of a pathological state in AD. 
Although the brain has always been considered the exordium site of neurodegeneration in 
AD, increasing evidence shows that the retina is also affected in the earliest stages of this 
disorder. It is well documented that in many AD patients the pathological state shows up first as 
problems with vision rather than memory or other cognitive deficits. Although historically the 
visual impairments have been linked to neurodegeneration of the cerebral cortex, in particular in 
the visual association cortex, more recent studies revealed that these are also due to disease of 
the optic nerve and retina (Berisha et al., 2007;Iseri et al., 2006). Thus AD, which is the most 
common form of dementia, shows among other neurodegenerative events, severe retinal 
abnormalities, resulting in visual function impairment due to changes in retinal structure and 
function, such as reduction of retina fiber layer, where axons of RGCs are located, retinal 
thinning, astrocytosis and activation of immune competent cells like microglia and Muller cells. 
Analysis of pattern electroretinogram in AD patients showed severe abnormalities, consistent 
with harsh dysfunction of RGCs (Berisha et al., 2007). Moreover, recent studies conducted on 
transgenic AD mouse models have shown Aβ deposits in the retina, associated with RGCs 
apoptosis and visual functional impairment, further supporting the hypothesis of a retinal 
degeneration in AD pathology (Normando et al., 2009). Finally, more recent studies revealed the 
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presence of Aβ plaques in postmortem eyes from AD patients and in suspected early stage 
subjects, consistent with brain pathology and clinical reports, while Aβ deposits were 
undetectable in age-matched non-AD individuals (Koronyo-Hamaoui et al., 2011). RGCs 
degeneration is preceded by several cellular mechanisms, including a chronic state of oxidative 
stress, a dysregulation of electrolyte homeostasis and modulation of several proteins and peptides 
(Berisha et al., 2007;Iseri et al., 2006). 
In light of these data, it is interesting to highlight that, being unprotected by the barrier 
constituted by the skull, the retina is the most exposed part of the CNS. Therefore, the retina is 
much more accessible to direct observation and to pharmacological treatments. We can thus 
consider the retina as a mirror of the pathological state of the brain, as an open window on the 
brain to directly inspect the neurodegenerative process.  
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Chapter 3 
The mammalian retina. 
 
Retina is the part of the eye that is responsible for the transmission of the visual signals to 
the central nervous system (CNS). It is the most exposed and thus the most accessible part of the 
CNS.  
 
 
Figure 1 
On the left, schematic representation of the vertebrate eye. L, lens; V, vitreous; NR, 
neural retina; ONH, optic nerve head; ON, optic nerve. On the right, histological image 
and diagram showing the different retina layers of an adult mammalian retina. A, 
amacrine cells; B, bipolar neurons; C, cone photoreceptors; G, ganglion cell; GC, 
ganglion cell layer; H, horizontal neurons; INL, inner nuclear layer; IPL, inner 
plexiform layers; M, Muller cell; NF, nerve fiber layer; NR, neural retina; ONL, outer 
nuclear layer; OS, photoreceptors outer segments; R, rod photoreceptors; RPE, retinal 
pigment epithelium. Adapted from Wallace et al., Stem Cells, 2011.  
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3.1 Structure and physiology of the mammalian retina. 
The adult retina is a laminated structure. It is delimited on the apical side by the retinal 
pigmented epithelium (RPE), a single layer of epithelial cells, while on the basal side is bordered 
by the vitreous, which is the fluid filled cavity separating the retina from the lens. The nuclei in 
the retina are strictly organized in three main layers, separated by the synaptic layers, which are 
called ”plexiform” layers. The light passes through the lens and the whole thickness of the retina 
and stimulates the photoreceptors. Photoreceptors can be divided in two types: cones, 
responsible for light vision, and rods, responsible for the dark vision. Their cell bodies are 
located in the outer nuclear layer, adjacent to the RPE. Photoreceptors make synapses in the 
outer plexiform layer with bipolar neurons, whose cell bodies are located in the inner nuclear 
layer (INL). In the inner plexiform layer (IPL) lay synapses between bipolar neurons and retinal 
ganglion cells (RGCs). The latter ones are located in the gangliar layer. The axons of RGCs are 
gathered together forming the optic nerve that exits through the optic disc and transmits the 
information to the visual processing centers in the brain (Wallace, 2011).  
Photoreceptors are the cell type responsible for light perception. They translate the light signal 
into chemical signal. The first step in phototranslation is the light absorption by the 
photopigments located in the outer segment of photoreceptors. Rods have only one type of 
pigment, while the cones have three different types: each pigment is characterized by an 
absorbance peak, thus resulting more sensitive to a specific wavelenght. Each pigment molecule 
is made up by two different parts: a component called “retinal” common  to all the pigments, and 
a second component named “opsin” that determines the sensitivity to the different wavelengths. 
The rod’s pigment is located in the membrane of “discs”. Discs are specific structures located in 
the outer part of the photoreceptor, like small invaginations that increase the total surface of the 
cell. Inside the discs there is Transducin, which is a G-protein, and the enzyme 
phosphodiesterase that catalyzes the degradation of cyclic GMP (cGMP). In the dark cGMP 
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levels in the photoreceptor are higher causing the opening of sodium channels. Sodium inflow 
determines a membrane depolarization that in turn opens calcium channels in the inner segment 
of the photoreceptor. The following increased calcium concentration causes the endocytic release 
of neurotransmitters that bind to receptors on the plasma membrane of bipolar cells.  
One of the pigments expressed by rods is Rhodopsin. After light exposure, the conformational 
change of the retinal causes the detachment of the opsin which in turn activates Transducin. 
Successively Transducin activates the phosphodiesterase resulting in decreased levels of cGMP. 
Thus, the resultant closure of sodium channels determines a membrane hyperpolarization. As a 
consequence, less glutamate molecules are released from the photoreceptor: the light presence is 
thus signaled. Cones work in a very similar way, but due to the different sensitivity of the 
photopigments, they are sensitive only to very restricted wavelengths (Germann, 2008).  
Once depolarized by the binding of glutamate released by photoreceptors, bipolar cells 
release the neurotransmitter that interacts with receptors present on the plasma membrane of 
RGCs. At the periphery of the retina, where only rods are present, many of them converge on 
each bipolar cell.  This allows a major light sensitivity. However, in fovea and macula, where 
cones predominate over rods, synaptic convergence is reduced and only few photoreceptors 
converge on the same bipolar cell. In this region retina is much more sensitive to the details of 
the images (Dacey, 1999).  
Bipolar cells are the neurons responsible to convey signals from photoreceptors to retinal 
ganglion cells. They can be categorized into two main classes: “diffuse” bipolar cells which have 
connections to multiple cones; and “midget” bipolar cells that have a single line connection to a 
single cone axon terminal (Wallace, 2011).  
The light collected by photoreceptors activates a signaling that propagates throughout the 
retina circuits, through bipolar neurons, to modulate the spike firing in RGCs. RGCs axons make 
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up the optic nerve that exits the eye through the optic disc and send the information to the brain. 
Most of the axons of RGCs project to the dorsal lateral geniculate nucleus (dLGN), and from 
there to the visual cortex. Some of their axons project to brain centers other information, for 
other visual functions such as circadian photoentrainment. According to the original idea, all the 
light signals involved rods and cones at first. However, further studies have demonstrated that a 
small subset of RGCs express melanopsin, a photopigment able to capture the light and activate 
the translational pathway. Indeed, mice with degenerated rods and cones change their circadian 
rhythm according to the external light-dark cycle, although they do it with a different spectral 
sensitivity from wild type mice. This is due to the presence of melanopsin-expressing RGCs in 
rodless and coneless mice.  
In binocular species some axons project ispilaterally (crossing the midline), and some project 
contralaterally. Axons from the nasal retina project contralaterally, while axons from temporal 
retina project ipsilaterally. Animals that have their eyes near the front of their head have a higher 
degree of binocular overlap (thus binocular vision) and thus a higher number of ipsilaterally 
projecting RGCs. Humans are highly binocular, with almost 40% of uncrossed (ipsilateral) 
RGCs axons. On the other hand, mice are a poor binocular specie, with around 3-5% of 
uncrossed axons. Retrograde staining of RGCs in mammalian retina allowed the identification of 
many different types of RGCs, classifying them according to their morphology and their 
electrophysiological properties. Although almost 19 different types of RGCs have been 
identified, they have been classified into 4 main groups, according to the size of their cell bodies 
and the extensiveness of their dendritic tree (Dacey, 1999;Sun et al., 2002). 
Horizontal cells are the lateral interneurons of the outer retina. Their dendritic processes 
innervate the axon terminals of the photoreceptors. Horizontal cells provide a negative feedback 
to photoreceptors, by modulating their synaptic contacts with bipolar neurons. They are 
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electrically coupled by gap junctions and form a sort of an “electrical syncitium”. (Wallace, 
2011). 
While horizontal cells are mainly responsible to modulate the synapses between 
photoreceptors and bipolar cells, amacrine cells modulate the synapses between bipolar cells and 
RGCs. Amacrine cells’ bodies are located in the INL together with bipolar neurons. A 
subpopulation of amacrine cells are the cholinergic amacrine cells, which are commonly called 
“starbucks” cells due to their typical morphology: they have four to five primary dendrites, each 
of them branching into secondary and tertiary processes. The dendritic arborization has a perfect 
symmetry around the soma, giving them their typical morphology. Due to the release of 
neurotransmitter such as acetilcholine, GABA and glutamate, they have a main role in 
modulating electrical signals coming from photoreceptors (Kolb, 1997;Lagnado, 1998). 
The retina also contains Muller cells, which are the main glial element in the vertebrate retina, 
providing structural and trophic support to neurons. They are disposed radially, spanning the 
whole thickness of the retina from the inner to the outer limiting membranes. The cell bodies of 
Muller cells are located in the INL. Their apical processes form adherens junctions with 
photoreceptors, while their endfeet are in contact with the basal lamina at the inner limiting 
membrane, near the vitreal surface of the retina. Muller cells are the last subpopulation cell in the 
retina to differentiate (Wallace, 2011). Muller cells activity occurs in many retinal diseases. 
Muller cells gliosis is characterized by both specific response such as increased expression of 
glutamine synthetase (GS) for example after photoreceptor degeneration; and non specific 
responses, such as glial fibrillar acidic protein (GFAP) expression as a “universal” marker of 
retinal injury (Bringmann and Reichenbach, 2001). Muller cell gliosis may involve a de-
differentiation and proliferation. The de-differentiation of Muller cells can be detrimental due to 
the impairment of neurotransmitter removal and unbalanced ion and water homeostasis that may 
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establish after the down regulation of potassium channels that accompanies Muller cells de-
differentiation (Bringmann et al., 2002). 
 
Figure 2 
On the left, schematic representation of a Muller cell. On the right, immunostaining of a 
Muller cell in a section from guinea pig retina. Adapted from Bringmann et al., Progress 
in Retinal and Eye Research, 2006.  
 
On the other hand, duplication may be detrimental by filling the space left by dying neurons, for 
example by dying photoreceptors in the retina detachment, establishing the so called “glial scar”. 
In the formation of a glial scar Muller cells processes form a fibrotic layer that completely 
inhibits regeneration of outer photoreceptor segments. Glial scars also involve the expression of 
inhibitory molecules that inhibit regular tissue repair and neuronal regeneration (Bringmann et 
al., 2006).  
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Retinal astrocytes form a dense network on the vitreal surface of the retina and are closely 
associated with the vasculature. Retinal microglia is a very meager cell subpopulation, and is 
“spread” throughout the layers, mainly scattered in the INL and OPL. However, its number 
increases in case of retinopathy that leads to neuronal degeneration (Huxlin et al., 1992). 
 
 
Figure 3 
Schematic diagram of neurotransmitter recycling in the retina. A GABAergic (neuron 1) 
and a glutamatergic neuron (neuron 2) release GABA and glutamate, respectively, into 
the extracellular space (ECS) from where they rapidly are taken up by the Muller cell. 
Thus, Muller cell expresses GAT-3 (GABA transporters) and GLAST (glutamate 
transporters). Once GABA has entered the cytoplasm, it is converted into glutamate by 
GABA transaminase (GABA-T). Then, glutamate is transformed into glutamine by the 
glia-specific enzyme, glutamine synthetase (GS). The GS reaction is the only pathway of 
ammonia detoxification in the retina. Glutamine is then exported by the glutamine 
transporters SN 1 and 2 into the ECS from where the neurons may take it up, and use it 
for the re-synthesis of glutamate and GABA. Adapted from Bringmann et al., Progress in 
Retinal and Eye Research, 2006.  
 
3.2 Retina development. 
In the beginning of retinal development the neuroepithelium is entirely consisting of 
progenitor cells, which are proliferating cells. The appearance of the first post mitotic neurons, 
the RGCs, which marks the onset of neurogenesis, starts at embyionic day 11 (E11) in mouse 
(Young, 1985). In all the vertebrates studied, RGCs are the first neurons to differentiate in the 
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retina, followed by all the remaining neuronal subpopulations. The temporal differentiation of all 
the retinal neurons is strictly regulated by a precise genetic program. Soon after RGCs, cones, 
horizontal cells and half of the amacrine cells develop. Muller glia, bipolar cells and the 
remaining amacrine cells develop mostly in the postnatal period. Rods start to be generated in 
embryonic life, and continue throughout the first two weeks of  post natal life (Wallace, 2011). 
Retinal neurogenesis is not only temporally regulated, but also spatially regulated. It starts in the 
central retina and “spreads out” towards the periphery. So, from a developmental point of view 
the central retina, where the axons of RGCs are gathered together forming the optic nerve and 
exit the retina through the optic disc, is more advanced than the peripheral retina. The 
proliferation phase of retina is followed by a period of morphogenesis that includes synapse 
formation, remodeling and morphological maturation. The morphogenesis period starts around 
postnatal day 7 and continues until P21 (Wallace, 2011). 
So the whole sequential production of retinal cell types takes place over approximately two 
weeks in rodents. 
A mechanism that precisely regulates the balance between proliferation and differentiation 
of progenitor cells is important to ensure the appropriate number and proportion between all the 
different cell subpopulations. This is controlled by a variety of transcription factors temporally 
expressed by the progenitor cells, such as positive regulators of progenitor cells proliferation like 
Rax, Six6 and Pax6, Sox2 as a regulator of neurogenic competence of progenitor cells, or Vsx as 
an inhibitor of retinal pigmented epithelium cells differentiation. Figure 4 summarizes the 
transcription factors involved in the specification of each single cell type. The activation of the 
different transcription factors depends on a combination of different intrinsic and extrinsic 
factors. For instance, it has been demonstrated that progenitor cells differentiate in specific ages 
independently of the environment in which they develop, demonstrating the importance of 
intrinsic signals in this mechanism. 
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Figure 4 
Temporal order of generation of the different cell types in mammalian retina, and 
regulation of retinal cell fate and development by transcription factors. Adapted from 
Wallace et al., Stem cells, 2011.  
 
However, the differences between the differentiation process in vivo compared to explants 
suggests that factors coming from the environment have sure a role in the appropriate temporal 
differentiation of progenitor cells in the different retinal subpopulations. The Notch-Delta 
signaling is one of the best characterized pathways regulating neurogenesis in retina. Inhibition 
of Notch signaling determines a precocious differentiation, while increased Notch activity delays 
differentiation, promoting the progenitor state. The interaction of Notch ligands, like Delta, with 
Notch receptors causes the translocation of the cytoplasmic domain of Notch to the cell nucleus 
where it interacts with its specific transcriptional co-activator altering gene expression. Micro 
RNAs also seem to be implicated in such processes (Wallace, 2011). 
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Interestingly, the plane and symmetry of cell division also is implicated in a specific 
differentiation fate. Indeed, it has been demonstrated that by altering the spindle orientation of 
dividing progenitor cells, probably by altering the concentration of some proteins, can alter the 
fate of dividing cells. The orientation of the division plane is modulated by the retinal pigmented 
epithelium, although the specific factors involved are yet to be identified (Wallace, 2011). 
The activation of a specific differentiation fate is then followed by a “maturation” stage that 
culminates into the formation of the complex retinal circuitry. For neurons this process involves 
the elongation of neurites and the differentiation into axons or dentrites. In the next chapter we 
will analyze this facet in more detail (Polleux and Snider, 2010). 
At the end of the neurogenic process and the formation of the adult laminated retina structure, 
Muller glia still contains progenitor genes and is able to re-enter the cell cycle. These ability of 
Muller glia has always attracted the attention of many scientists, seeing a potential therapeutic 
use of these cells following neurodegeneration in eye diseases such as glaucoma, retinitis 
pigmentosa, age related macular degeneration. In fish, Muller glia are stem cells and retain the 
ability to regenerate neurons. However, in mammalian retina, although Muller glia proliferation 
can be reactivated by Notch, the neurogenic potential is very limited, at least in vivo. However, 
they can be induced to proliferate and differentiate in retinal neurons in vitro (Bringmann et al., 
2006).  
Many attempts of cell replacements in order to restore vision after neurodegeneration 
induced by different factors have been performed, made possible by the relative accessibility of 
the retina to external manipulations. For example, diseases primarily caused by retinal pigmented 
epithelium dysfunction, like age-related macular degeneration, are now in clinical trials, by the 
transplantation of new healthy retinal pigmented epithelium cells in order to restore vision 
(MacLaren et al., 2007). Of course, replacement of degenerated neurons is far more complicated, 
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due to the difficulty of the neurons to form new synaptic contacts and correctly integrate in the 
complex retina circuits. 
Mature RGCs are typical CNS neurons and thus they possess only weak intrinsic potential to re-
grow injured axons following an optic nerve lesion. However, RGCs are switched into a robust 
regenerative state when β- and γ−crystalline proteins are released from an injured lens. In this 
state mature RGCs extend axons in culture at higher growth rates, and regenerate lengthy axons 
into an injured optic nerve in vivo (Ying et al., 2008). 
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Chapter 4 
Actin and Tubulin cytoskeleton in neuronal maturation.  
 
A crucial process in neuronal maturation, during its integration into the retina circuitry 
towards the formation of an adult fully functional retina, is neuronal morphogenesis. During this 
process the cell becoming a neuron expresses specific neuronal markers. Moreover, the ion 
channel composition and the expression of transporters changes abundantly during this period 
(Zolessi et al., 2006). 
A key step in neuronal morphogenesis is polarization, when neurites differentiate either into 
axons or dendrites. Once exited the cell cycle, the cells designated to become neurons migrate 
towards their final destination, and most neurons undergo their polarization during this 
migration. After the determination of a neuritis fate into axons, the elongation process takes 
place.  
 
4.1 Neuronal polarization in retinal ganglion cells. 
It has been demonstrated that in vitro hippocampal neurons go through different stages. Just 
after plating, the cells send out many thin and flat structures named lamellipodia. In stage 2, 
lamellipodia grow into minor neurites. Stage 2 is followed by stage 3 in which lamellipodia 
elongate. One of them starts to grow preferentially becoming the axon, while the others 
differentiate into dendrites in stage 4. In stage 5 neuron undergoes the final step of maturation. In 
vivo the scenario is a little different and far more complex, due to the necessity of the cell to 
integrate signals belonging to surrounding cells (Polleux and Snider, 2010). 
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However, the mechanism of polarization is quite different amongst the different neuronal 
types, and retinal ganglion cells (RGCs) work in a slight different way. Polarization of RGCs is 
prevalently inherited by the initial polarity of progenitor cells. Once the cells exit the cell cycle, 
they already have a proper apico-basal polarity. During migration from the retinal pigmented 
epithelium (RPE) to their final destination, signals belonging to the basal lamina cause the 
emergence of a leading process from the basal side, that starts growing in the direction of 
migration, and a tailing  (“retracting”) process on the apical side that keeps in contact with the 
apical surface.  
 
Figure 1 
Schematic representation of in vivo RGCs maturation. RGCs go through different 
maturation stages and migrate from the basal lamina (BL) towards the inner limiting 
membrane (ILM), in response to factors released by the retinal pigmented epitelium 
(RPE). Adapted from Randlett et al., Developmental Neurobiology,2010. 
 
During the migration of the cell body towards the vitreal surface, the apical process starts to 
retract, along with the basal neurite elongation, differentiating into axon. While the first one will 
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become the axon, the opposite will differentiate into dendrite. Axon differentiation usually 
precedes the retraction of dendrites on the opposite side, even though the leading process 
elongation is independent from the retraction of the apical process (Barnes and Polleux, 2009). 
In vivo studies have demonstrated the role of extracellular cues from the basal lamina in neuronal 
polarization of RGCs (Randlett et al., 2011). Moreover, the destruction of the inner limiting 
membrane causes an abnormal axon outgrowth, further demonstrating the importance of this 
structure in neuronal polarization. 
Although the importance of external cues in the polarization process of RGCs has been 
established, there are also many intrinsic signals guiding neuronal polarization. Indeed, in vitro, 
RGCs maturation appears quite similar to what happens in hippocampal neurons: during the 
differentiating process the cell undergoes a multipolar stage: all the neurites are identical and 
only successively one of them starts to grow faster, becoming the axon. 
 
4.2 Intrinsic signals regulating neuritis specification. 
Different intrinsic mechanisms are involved in axon specification and axon outgrowth, 
including local protein degradation, by regulating spatial protein expression. In dorsal root 
ganglion (DRG) cells the protein kinase AKT degradation has been shown to be involved in 
axon specification. The inactive form of AKT is degradated, resulting in an increased pool of 
active AKT over the inactive form (Randlett et al., 2010). 
Local translation is also a key mechanism in axon specification. The translation machinery is 
indeed present in growing axons. Rossol and colleagues demonstrated the importance of local 
translation of actin mRNA in growing axons (Rossoll et al., 2003).  
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cGMP levels are also involved in branching. In particular, the balance between cAMP and 
cGMP is important in neuronal polarization and neuritis differentiation into axon and dendrites. 
A shifted balance in the direction of cGMP over cAMP promotes dendrites differentiation over 
axons (Shelly et al., 2010).  
cAMP levels that drive axon differentiation are regulated by different agents, including brain-
derived neurotrophic factor (BDNF). Indeed, BDNF stimulation directs axon identity of neurites 
over dendrites (Goldberg et al., 2002).  
cAMP is a wide second messenger involved in many cell functions  (Gabellini, 2004;Pandey, 
2004;West et al., 2001). Its increased concentration modulates several different ion channels 
(Lolicato et al., 2011;Meyer et al., 2002;Wang et al., 2001;West et al., 2001). It is known that 
Forskolin, by activating the adenilate cyclase, increases cAMP levels and results in cell 
depolarization (Goldberg et al., 2002). The cAMP pathway is also physiologically activated by 
the pituitary adenylate cyclase activating polypeptide (PACAP). PACAP is widely diffused in 
different mammalian tissues, including retina. It exerts its specific response by binding to 
specific receptors. In retina there are two types of PACAP receptors: PAC1R and VPAC1 and 2. 
The first one is more specific. Both types activate the adenylate cyclase, resulting in increased 
cAMP concentration that in turn results in CREB (cAMP responsive element binding) 
phosphorylation and subsequent activation. CREB activation, that in neonatal retinas happens 
already after 5 minutes of stimulation, translocates to the cell nucleus activating a specific 
genetic program (Atlasz et al., 2010;Vaudry et al., 2009).  
In vitro studies, showed that other factors are involved in regulating axon specification. For 
example, the coating has a key role in this process. It has been shown that laminin is a key 
component in neuronal polarization (Barnes and Polleux, 2009;Shelly et al., 2010). Many studies 
demonstrated that the interaction with the extracellular matrix (ECM) is crucial in many cellular 
processes such as migration, proliferation or differentiation. The main receptors involved in the 
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transduction of the “signal” induced by the ECM are integrins, that translate the biochemical 
signal, across the plasma membrane, to the intracellular pathway. However, ECM may affect 
RGCs neuritogenesis and survival by inducing different signaling pathways during the different 
developmental stages. Indeed, while laminin coating promotes neuritis elongation at the 
beginning of the development stages, it results in axon outgrowth inhibition in rat retinas 
deriving from 2 weeks old animals, most likely by modulating the action of protein kinase C 
(PKC). Laminin is one of the main component of the ECM in the visual system, and its opposite 
effects on axon outgrowth in the different development ages, further support the importance of 
the basal lamina in the polarization process (de Ary-Pires and Linden, 2000;Goldberg et al., 
2002;Randlett et al., 2011). 
 
Figure 2 
Schematic drawing of PACAP activated signaling pathway in retina. PKC, protein kinase 
C; PKA, protein kinase A; cAMP, cyclic 3,5-adenosine  monophosphate; PAC1, VPAC1, 
VPAC2, PACAP receptors; PLC, phosholipase C; JNK, caspase-3, AIF (apoptosis 
inducing factor), proapoptotic factors; ERK, Bad, Bcl-xL, antiapoptotic factors; CREB, 
cAMP response element binding protein.  
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Many studies have also demonstrated the importance of electrical activity not only in 
neurons survival, but also in neuronal maturation. It has been demonstrated the potentiating 
effect of depolarization on BDNF-induced axon outgrowth. RGCs are the only neuronal 
subpopulation in the retina able to produce burst of action potentials, and stimulating their 
intrinsic electrical activity favors their development. RGCs are indeed already electrically active 
far before the photoreception starts. Thus, the stimulation of electrical activity in RGCs, by 
inducing the firing, promotes axon outgrowth (Goldberg et al., 2002).  
In other neuronal cell types, such as cerebellar neurons, voltage gated sodium channel 
tetrodotoxin- (TTX) sensitive are involved in axon outgrowth. Indeed, the inhibition of sodium 
channels impairs axon outgrowth by reducing cell excitability (Brackenbury et al., 2010).   
Other ion channels, other than TTX-sensitive sodium channels, are involved in axon outgrowth. 
Clapham’s lab demonstrated a role of TRPC channels in neurite outgrowth. Due to their specific 
localization at the growth cones they control growth cones morphology (Greka et al., 2003). On 
the other hand, Jablonka and colleagues showed the role of calcium channels in neurites growth 
of motor neurons. Neuronal growth cones, indeed, undergo multiple intracellular calcium 
elevations every hour and these calcium waves have been inversely correlated to neurite 
elongation. Indeed, culturing cells in calcium free medium causes an increase of axon length, 
while restoring the physiological extracellular calcium concentration, by reducing growth cones 
adhesion to the substrate and growth cone dynamics, overall reduces axon outgrowth. In vivo 
axon length is increased when spontaneous calcium waves are reduced (Jablonka et al., 2007). 
Regarding chloride channels involvement in this process, many studies reveal the key role of 
ligand-gated chloride channels in neuronal maturation. However, not much is known about the 
role of voltage gated anionic current in this process. It has been demonstrated the role of GABA 
and glycine receptors in this process in cerebellar granule neurons, in hippocampal neurons and 
cortical neurons. Due to the higher intracellular chloride concentration in immature neurons, 
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their activation causes a chloride-mediated depolarization. This results in increased calcium 
concentration by regulating voltage gated calcium channels (Sernagor et al., 2010). Recent 
studies have shown the involvement of chloride channels in differentiation and neuritis 
elongation of PC12 cells induced by NGF treatment. NGF treatment elicits a chloride current 
that in turn determines the phosphorylation of TrkA receptor and the activation of the ERK 
pathway. The treatment with chloride channels inhibitors such as DIDS, SITS and NPPB, that 
are widely used blockers of volume-regulated chloride current,  greatly reduced neurites length 
of NGF treated PC12 cells and TrkA activation (Kim et al., 2010). Moreover, it is known the role 
of chloride, and in particular of GABA receptors, in dendrites maturation of cortical neurons 
(Sernagor et al., 2010).  
 
4.3 Tubulin cytoskeleton in neuronal polarization. 
Many studies have demonstrated the importance of cytoskeletal dynamics in axon 
specification. Actin and tubulin are the main constituent of the neuronal cytoskeleton. Actin 
filaments regulate the shape of the growth cone and the direction of axon growth, whereas 
microtubules gives structure to the axon and are essential for axon extension.  
Tubulin is a 54 KDa protein and is a widely diffused protein in vertebrates. Polymerization 
of microtubules proceeds through the heterodimerization of α- and β-tubulin into protofilaments 
that associate into a polar structure. This polarity is responsible for different polarization rates at 
the two microtubules ends: the fastest polymerization rate at the plus end (“capped” by β 
subunits) and the slowest polymerization rate at the minus end. There are six different genes for 
α-tubulin and seven genes coding for β-tubulin in mammals. βIII-tubulin is normally expressed 
only in neurons, while the βII-isoform is usually predominantly expressed in elongating neuronal 
processes. However, microtubules are usually heterogeneous polymers composed by different 
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combinations of the different tubulin isoforms. The different tubulin isotypes confer different 
properties to the microtubules; for example βIII-tubulin-microtubules are more stable than those 
assembled almost exclusively by βII-tubulin. Moreover the different tubulin isotypes 
composition alters the microtubules dynamics. Different proteins are associated with 
microtubules contributing to neuronal stabilization (Poulain and Sobel, 2010).  
Microtubule cytoskeleton dynamics is important in axon outgrowth. APC protein is involved 
in microtubule dynamics, by binding to plus end of microtubules. APC is a target of GSK3β 
kinase. Phosphorylation of APC by GSK3β reduces its binding to microtubules. GSK3β 
regulates by phosphorylation also two other microtubules binding proteins, such as MAP1β and 
Tau. Both protein bind to microtubules and are regulated by phosporylation. It is known that Tau 
hyperphosphorylation causes its detachment from microtubules impairing axonal transport and 
causing abnormal Tau aggregates common in Alzheimer Disease and other tauopathies.  
The opposite role of PTEN phosphatase and PI3K on the PIP2 pathway, are also involved in 
axon outgrowth. PTEN is a protein- and lipids-phosphatase, and its activity ensures, among 
others, the correct lipid composition of the growth cones membranes during neuronal 
polarization (Polleux and Snider, 2010). 
Other signaling pathways like the ERK/MEK, or the JNK pathway are involved in axon 
elongation. Moreover, it has been demonstrated the involvement of atypical PKC (aPKC) in this 
process, acting on Par-3 and Par-6, LKB1, Ras- and Rho-family small GTPases (Polleux and 
Snider, 2010). 
 
4.4 The actin cytoskeleton in axon outgrowth: the growth cones. 
Monomeric actin (G-actin) is 42 KDa protein, binding either ATP or ADP. In vitro, ATP-
actin rapidly polymerizes into polarized filamentous structures: the F-actin. F-actin is composed 
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by two twisted helices. Once F-actin starts nucleating, the polymerization process proceeds 
quickly by adding monomers at the plus end, and proceeds more slowly at the minus end. 
Capping proteins associate at the plus or the minus end, resulting in a tight regulation of actin 
polymerization, either preventing filament elongation or inhibiting depolymerization. Monomer 
binding proteins control the availability of actin subunits, while the so called severing proteins 
such as the members of the Cofilin family regulate disassembly (Nurnberg et al., 2011). 
Actin cytoskeleton results to be highly enriched at  the tips of growing axons, in structures 
called growth cones, that guide axon outgrowth (Geraldo and Gordon-Weeks, 2009).  
During neuritis development, growth cones pass through different environments and integrate 
several cues encountered along their pathway. 
Growth cones are the most distal part of growing axons. Growth cones are highly dynamic 
structures, with a typical fan-shaped morphology made up of a central tubulin-rich area, 
surrounded by an actin-rich area, as shown in figures 3 and 4. Thus, it is likely that subtle 
alterations of the cytoskeletal dynamics are tightly linked to axon outgrowth, and the fine 
structure of the growth cone is one of the first affected. Growth cones probe the environment 
searching for specific cues, by protruding and retracting flat protrusions called lamellipodia and 
finger-like projections named filopodia (Dent et al., 2011). The dynamics of the cytoskeleton at 
the growth cone is crucial for axon outgrowth. The balance between cytoskeleton polymerization 
and depolymerization sets the neurite extension. The pioneering studies of Bradke and Dotti in 
1997 showed that increasing the actin cytoskeleton dynamics by local perfusion of actin-
depolimeryzing agents, such as Cytochalasin or Latrunculin, might be sufficient to induce the 
axon-determination. Indeed, axons usually grow ten times more and faster than dendrites, and 
favoring actin depolymerization  is sufficient to increase actin dynamics and thus induce a faster 
neurite elongation and axon differentiation (Bradke and Dotti, 1997).  
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Figure 3 
Schematic representation of the morphological regions constituting a growth cone 
cytoskeleton. The microtubules in the axon shaft (green lines) are mantained parallel to 
each others through MAPs (microtubules associated proteins). They extend individually 
in the C-domain and in the T-zone.  The P-domain is dominated by parallel filament of 
Factin. Adapted from (Geraldo and Gordon-Weeks, 2009). 
 
Many accessory proteins are involved in the tight control of the balance between polymerization 
and depolymerization, shaping the growth cone. One of the main capping proteins is Cofilin. 
Cofilin can bind both to G-actin and F-actin. When bound to F-actin it causes filament twisting 
leading to actin depolymerization, while bound to G-actin prevents F-actin polymerization. Thus 
Cofilin contributes in controlling growth cones morphology and axon elongation.  
Actin dynamics is also important in growth cones guidance towards specific cues. 
Depolymerizing agents, indeed, do not impair axon outgrowth, but neurons treated with these 
specific agents are no more able to turn respectively towards or away from specific guidance 
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cues. The mechanism is not common to all the neuronal types, indeed, for example, the severing 
protein Cofilin is important for turning of hippocampal axons, but not for cerebellar neurons 
(Dent et al., 2011;Gehler et al., 2004).  
 
 
Figure 4 
Representative image of a growth cone, with the tubulin rich area (magenta) surrounded 
by the fan-shape of F-actin (red). 
 
The importance of actin at the growth cones for axon elongation is supported by the studies 
showing that a local translation of actin mRNA at the growth cones help in the neurite growth, 
although the molecular mechanisms involved in this process are not fully understood (Rossoll et 
al., 2003).  
Impairment of axon outgrowth is usually accompanied by altered morphology of growth cones. 
Davis and colleagues demonstrated that knock out mice for the β-subunint of the CP protein have 
altered morphology of the growth cone, with a collapse of the structure, and an increased co-
localization of actin and tubulin, accompanied by a reduced axon length (Davis et al., 2009). 
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AIM OF THE WORK 
 
Due to the broad expression of CLIC1 throughout the central nervous system (CNS), and more 
importantly to the crucial role of CLIC1 in the CNS physiopathology, as a result of its peculiar 
property to respond to cellular oxidation by moving from the cytosol to the plasma membrane, 
we hypothesized the involvement of CLIC1 in other oxidation-based mechanisms in the CNS. 
Recent studies showed severe retinal dysfunctions in Alzheimer disease (AD) patients, due to the 
loss of retinal ganglion cells (RGCs), much before other cognitive symptoms. RGCs are the cells 
whose axons gather together making up the optic nerve, and many studies have demonstrated 
that RGCs degeneration is linked to oxidative stress. Thus, we hypothesized a role of CLIC1 in 
this mechanism. Interestingly, not being protected by the skull, retina is the most exposed and 
thus the most accessible part of the CNS.  Therefore, we focused on the retina in the search for 
an early diagnosis of the neurodegenerative process in AD.  
Moreover, due to the broad expression of CLIC1 in mouse retina and in cultured RGCs, we 
investigated on the role of CLIC1 also in RGCs physiology and in particular in the development 
process of the optic nerve.  
.  
 
57 
 
Chapter 5  
Methods 
 
Confocal microscopy. Confocal microscopy was pioneered by Marvin Minsky in 1955 while he 
was a junior fellow at  Harvard. Confocal microscope brings up considering improvements over 
other conventional fluorescence microscopes: in primis, the possibility of collecting light from a 
single focal plane of the sample, by a point-by-point illumination of the specimen. In this way it 
is possible to exclude most of the scattered light belonging to the excitation of other focal planes 
of the sample, rendering the image sharper and the details more defined: the image results less 
blurred and represents a thin section of the sample. Thus not only images are more defined, but it 
is also possible to assemble a series of thin slices along the vertical axis re-creating a 3D image. 
 
Figure 1. 
Schematic representation of a confocal microscope. 
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In order to collect light from a single point of the sample at the time, a high intensity source of 
light is needed. In confocal microscopes this is provided by illuminating the sample with a laser. 
In Figure 1 is shown a schematic representation of a confocal microscope. The fluorescent 
specimen is excited by the blue laser light with the help of a dichroic mirror. Two rotating 
mirrors that direct the laser light through the sample allow to scan the whole specimen. The 
green light emitted by the specimen is collected through the same rotating mirrors, through the 
dichroic mirror, to the pinhole. The pinhole allows to define the size of the point excited by the 
laser light. In the end the signal is detected with a photomultiplier (PMT). Given that only one 
point at the time is excited every instant, there is never a complete image, that is rebuilt only on a 
computer, one pixel at the time. The image created by the microscope is a thin region of the 
specimen, which we use to refer to as an optical section: out-of-plane unfocused light has been 
rejected. 
In order to visualize these images, a fluorescent sample is needed. Specific proteins in cells and 
tissues are labeled by specific primary antibodies. Primary antibodies are recognized by specific 
secondary antibodies that are conjugated to fluorescent molecules. This allow to visualize under 
a fluorescence microscopes the labeled molecules. 
In this case all the images were acquired with a Leica SP5 microscope, excited with either 405 or 
488, or 546, or 647 laser.  
 
5.1 Extraction of retinas from rat and mice. Adult mice were anesthesized with isofluorane 
and enucleated, then sacrificed by dislocation. The eyes were kept overnight at 4°C in 4% 
paraformaldheyde (PFA). A small hole in the cornea helped the penetration of PFA into the 
internal tissue. After 24 hours the eyes were washed several times in PBS in order to eliminate 
any residual PFA, and left overnight (ON) in 30% sucrose, in order to dehydrate the tissue that 
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otherwise would result damaged once frozen. The last day the eyes were included in OCT and 
frozen in dry ice. After one day, 20 µm slices were made at the microtome. 
5.2 Immunohistochemistry. Retina slices were washed twice in PBS and blocked for 2 hours at 
room temperature (RT) in 5% BSA and 0.5% Triton X-100. Then the excess was removed and 
the slices were incubated ON at 4°C in PBS with 1% BSA, 0.2% triton X-100 and primary 
antibody. Anti-CLIC antibody (custom made, kindly provided by Dr Mark Berryman at Ohio 
University College of Osteopathic Medicine (Athens, OH) was diluted 1:400; anti-tubulin 
(Sigma Aldrich) 1:300. After 3 washes with PBS they were incubated with their specific 
secondary antibody diluted 1:1000. For CLIC1, anti rabbit 546; for tubulin, anti mouse-660. The 
slices were then washed with PBS and incubated for 10 minutes in PBS containing Hoechst 
(1:400), and mounted with Fluoromount G (Southern Biotech). 
5.3 Mice. TgCRND8 mice and their control littermates (non transgenic mice with C3H/B6 
background) were used. TgCRND8 encode a double-mutant form of amyloid precursor protein 
(APP) 695  (KM670/671NL+V717F) under the control of the Prion Protein gene promoter 
(Chishti et al., 2001). 3xTg mice (carrying three mutations respectively in the APP gene, in Tau 
gene and in Presenilin gene) and their control littermates  (carrying only the PS1 mutation) were 
used (Oddo et al., 2003). C56BL6 mouse pups from Charles River were used to isolate RGCs. 
5.4 Brain slices preparation. Mice were anesthetized and perfused with saline, then brains were 
removed, bisected in the mid-sagittal plane and  fixed in 10% neutral buffered formalin for a 
minimum of 48 h. The specimens were then processed on an automatic tissue processor 
overnight with vacuum to aid penetration of the fixing solution. Paraffin sections were cut at 5 
µm. Sections were stained with DAPI, and Lectin-488 in order to visualize activated microglia 
cells.  
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5.5 Immunohistochemistry on brain slices. Brain sections were rinsed 3 times and then placed 
in blocking solution (PBS, pH 7.4 with 0.3% Triton X-100, 2% BSA and 5% Goat Serum), for 
30 min at RT. Biotinylated Lycopersicon esculentum agglutinin (LEA) (1:2000; Vector 
Laboratories) was diluted in fresh blocking solution, applied for 1 h at 4°C and revealed by 
streptavidin-Alexa 488 (1:1000, Invitrogen). Following 3 additional rinses, sections were finally 
coverslipped using Vectashield water-based mounting medium with DAPI (Vector Laboratories, 
Burlingame, CA). 
5.6 Dissociation of retinal ganglion cells. Retinal ganglion cells were isolated by immuno 
panning from P1 mouse retinas, as previously described (Goldberg et al., 2002). Briefly, mouse 
pups were enucleated and the eyes were put in neurobasal medium (Invitrogen). A small hole on 
the cornea was made in order to decrease the pressure and allow an easier manipulation of the 
eye. The retinas were isolated and put in fresh pre-warmed neurobasal. The tissue was then 
digested at 37°C for 30 minutes in a digestion solution containing 16 U/ml papain (Roche), 0.04 
mg/ml DNAse (Roche), and 1.3 mg/ml L-cysteine (Sigma Aldrich) added only 10 minutes 
before the digestion in order to activate papain. Successively, digestion solution was removed 
and the tissue was carefully washed three times with ovomucoid solution containing trypsin 
inhibitor (Roche) 15 mg/ml, BSA and 0.04 mg/ml DNAse, letting the pieces to settle after each 
wash. Then the digested tissue was resuspended in 5 ml ovomucoid solution and gently subjected 
to a mechanical digestion. The cells were counted and after centrifugation at 400g they were 
resuspended in 360 µl of a pre-warmed separation buffer containing 0.5 mg/ml BSA and 2mM 
EDTA, in PBS. The cells were then incubated for 10 minutes at 4°C with 1:100 anti Thy1.1 
antibody conjugated to magnetic microbeads (Milteny). Thy 1.1 is a membrane protein 
specifically expressed by RGCs in the retina. The antibody binding to Thy1.1 allowed to isolate, 
by a magnet, all the cells expressing Thy1.1 in the retina (specifically bound by the antibody). 
Thus, we were able to isolate RGCs over the other retinal subpopulations. After 10 minutes 
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incubation, the antibody in excess was removed by washing the cells with separation buffer, and 
centrifuged at 300g for 10 minutes at RT. The cells were successively resuspended in 3 ml of 
separation buffer. The cell suspension was added to the affinity column placed in a strong 
magnetic field. Only Thy1.1-labeled cells were thus kept in the column, while all the remaining 
cell subpopulations flew through it. After washing the column with 2 ml of separation buffer to 
eliminate the cells unspecifically bound to the column, the column was removed from the 
magnetic field and the cells were eluted with 5 ml of separation buffer. Eluted RGCs were 
counted, centrifuged at RT for 10 minutes at 300g, and resuspended in culture medium. The cells 
were plated at a density of 55000 cells per each well. The culture medium contains: 100 µg/ml 
Transferrin (Sigma aldrich), 100 µg/ml BSA (Sigma aldrich), 60 ng/ml Progesterone (Sigma 
aldrich), 16 µg/ml Putrescine (Sigma Aldrich), 40 ng/ml sodium selenite (Sigma aldrich), 2X 
serum-free B27 supplement (Invitrogen), 40 ng/ml T3 (Sigma Aldrich), 1 mM sodium pyruvate 
(Sigma), 2 mM glutamine (Sigma aldrich), 50 ng/ml Insulin, 10 µM Forskolin, 50 ng/ml BDNF, 
100 ng/ml CNTF (Invitrogen). The cells were kept at 37° and 5% CO2. The slides were pre-
coated with 10 µg/ml poly-D-lysine for 30 minutes and with 10 µg/ml Laminin overnight. 
5.7 Electrophysiology recordings. 7 DIV RGCs were bathed in a physiological solution 
containing (in mM) 140 NaCl, 5 KCl, 2.5 CaCl2, 1 MgCl2, 10 Hepes, 10 Glucose. Membrane 
potential recordings were performed in gramicidin perforated patch. 2.5 µg/ml gramicidin was 
dissolved in pipette solution containing (in mM) 140 KCl, 10 Hepes, 10 Glucose.  
5.8 Amyloid beta preparation. Aβ powder (Bachem) was resuspended in water-free DMSO at 
1 mg/mL concentration, by shaking it for 90 minutes. Then it was placed at -80°C for 45 
minutes. It was placed still frozen in a lyophilizator overnight at -20°C under centrifugation. The 
fluffy pellet was stored at -20°C until use. Just before use, Aβ was dissolved in DMSO, 
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quantified by using BCA kit (Pierce) according to the manufacturer instructions, and dissolved in 
bath solution. 
5.9 RGCs treatment. All the treatments were performed by diluting the compounds in the 
culture medium. IAA94 (dissolved in ethanol) was dissolved in the culture medium at a final 
concentration of 50 µM. DIDS (dissolved in DMSO) was diluted at a final concentration of 200 
µM. Anti N-ter CLIC1 antibody (kindly provided by Dr Sam Breit, University of Sidney) was 
diluted 1:100 in culture medium. For axon length quantification the cells were cultured for 24 
hours, while for growth cones analysis they were cultured and treated for 3 days. 
5.10 Immunocitochemistry on isolated retinal ganglion cells. RGCs were fixed for 45 minutes 
in pre-warmed 4% paraformaldehyde (PFA), than washed 3 times with PBS and incubated 2 
hours at RT with blocking solution containing PBS with 5% BSA and 0.1% Triton X-100. They 
were successively incubated overnight (ON) with anti-CLIC1 antibody (kindly provided by Dr 
Mark Berryman at Ohio University College of Osteopathic Medicine (Athens, OH)) diluted  
1:400 in antibody incubation solution (PAIS) containing PBS with 1% BSA and 0.1% triton X-
100. The cells were then washed twice in PBS and incubated with the appropriate secondary 
antibody, anti rabbit-546 diluted 1:1000 in PAIS. After 2 washings in PBS, anti-beta tubulin III 
(Millipore) diluted 1:300 in PAIS was added ON at 4°C. Then the cells were washed and 
incubated with secondary anti-chicken antibody alexa-660 diluted 1:1000 in PAIS, for 2 hours at 
RT. After 3 washings the cells were incubated in a solution containing PBS, 1% BSA and 
phalloidin-488 (Invitrogen) for 30 minutes at 37°C. During the last 3 washings the cells were 
incubated with Hoechst diluted 1:400 in PBS and mounted with Fluoromount G (Southern 
Biotech). 
5.11 Axon length quantification. Tubulin-labeled RGCs were visualized with a Olympus BX51 
Neurolucida microscope, using a dry 20X objective. The cells were excited with a fluorescence 
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lamp, and excited and acquired by using the appropriate filters. Only neurites longer than the cell 
body diameter were considered, and the longest axon of each neuron was measured and averaged 
with the axons of other cells.  
5.12 Co-localization analysis. Co-localization between actin and CLIC1, and between  tubulin 
and CLIC1 at the growth cones was performed by using the ImageJ software. In order to define 
the area of analysis, a “mask” was created based on the phalloidin labeling, and the number of 
co-localized pixels was counted and expressed as a percentage of the total mask area (considered 
as 100%).  
5.13 Quantification of altered growth cone morphology. The area of the mask created on the 
phalloidin (actin covered surface, AcS) and on the tubulin labeling (tubulin covered surface, 
TcS) was measured and the “absolute value” was considered for the ratio. 
 
Figure 2. 
Map of pIRES2-EGFP plasmid in A, and of the pEGFP-N1 in B. 
 
5.14 Cell cultures. N2a (ATCC CCl-131) and HEK293T (human embryonic kidney) (ATCC 
CRL-11268) were kept in Advanceded D-mem (Invitrogen) containing 10 % Fetal bovine serum 
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(FBS), 2 mM glutamine, 1X Pen strep, at 37°C and 5% CO2. The cells were split every 3 days by 
incubating for 5 minutes at 37°C with Trypsin-EDTA (Invitrogen) and re-plated at 1:10 dilution. 
5.15 DNA and cell transfection. CLIC1 gene was inserted in the pIRES2-EGFP plasmid (see 
map in figure 2) into the BglII-BamHI sites; and in the BglII-BamHI sites also into the pEGFP-
N1. 60% confluence N2a cells were transfected with a mixture of Lipofectamine : DNA = 3 µl : 
1 µg, in serum-free medium. After 5 hours post transfection an equal volume of medium 
containing 20% FBS was added in order to restore the final concentration of 10% FBS. All the 
experiments were performed 48 hours after transfection. 
5.16 Western blot analysis. Cells were lysed for 30 minutes in ice with 150 µl Lysis buffer 
containing 50 mM Tris pH 7.4, 1% Triton X-100, 50 mM NaCl, 1 mM EDTA, protease inhibitor 
cocktail. After 30 minutes the cells were detached with a scraper and each sample was sonicated 
for 1 minute. The sample was briefly centrifuged at 4000g in order to roughly eliminate the 
membrane fraction, and the supernatant containing the cytoplasmic fraction was loaded on a 
10% acrylamide gel and run at 130 V for 2 hours. Then it was blotted on a 0.2 µm nitrocellulose 
membrane for 2 hours at 4°C at constant 200 mA current applied. The blot was then blocked for 
1 hour with TBS containing 5% milk and 0.2% tween-20, by shaking it at RT. After blocking, it 
was incubated with anti-CLIC1 antibody (kindly provided by Dr Sam Breit, University of 
Sidney) diluted 1:800 in TBS with 1% BSA and 0.2% Tween-20, ON at 4°C. After 3 washings 
with TBS (5 minutes each), it was incubated with the appropriate secondary antibody (Alexa 
goat anti sheep-488), 1:1000 for 2 hours at RT in the dark, in shaking. After 3 washings in large 
volumes of TBS the membrane was left to dry up for 30 minutes and then the signal was 
detected at the typhoon, by exciting with 488 laser. Anti-actin antibody (Sigma) was diluted 
1:500 in the same solution and detected with anti-rabbit-546 secondary antibody.  
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5.17 Cytochalasin treatment of N2a cells. N2a cells were treated with the vehicle and with 10 
µM cytochalasin B (Sigma Aldrich) for 60, 90 and 120 minutes respectively. The cells were then 
lysed for 30 minutes in ice in 150 µL lysis buffer containing: 50 mM NaCl, 50 mM Tris pH 7.8, 
1 mM EDTA, 0.1% Triton X-100, protease inhibitor cocktail. Differently from the previously 
mentioned lysis buffer, here the percentage of Triton X-100 was much lower in order to keep the 
eventual interaction between Actin and CLIC1. The cells were then homogenized in a Dounce 
and centrifuged for 45 minutes at 4°C and 100000g, in order to separate the soluble fraction from 
the unsoluble fraction. The unsoluble fraction was then resuspened in the same lysis buffer 
containing also 0.1% SDS. The samples were quantified with BCA kit according to the 
manufacturer instructions and run on a acrylamide gel as described above.  
5.18 Statistical analysis. Data were presented as mean values ± standard error of the mean 
(s.e.m.). The significance was calculated with two sample student-T-test by using Origin 
software, with 0.05% significance. 
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Chapter 6 
Results 
 
6.1 CLIC1 as an early marker of neurodegeneration in AD. 
Visual deficits often accompany and, most importantly, precede cognitive impairment in 
Alzheimer disease (AD) patients, due to the loss of Retinal ganglion cells (RGCs) (Berisha et al., 
2007). Being unprotected by the skull, retina is the most accessible part of the central nervous 
system (CNS). Previous studies have documented the expression of CLIC1 throughout the CNS. 
(Milton et al., 2008;Novarino et al., 2004). Thus, in the search for an early marker of AD that 
could represent an useful tool for an easy diagnosis of the disease, necessary for an appropriate 
medical therapy, we investigated CLIC1 expression in the mammalian retina.  
Figure 1 depicts an image of a mouse retina section. DAPI labeling, in blue (upper left panel), 
allows to visualize the different retina layers; as indicated in the figure: the photoreceptor layer, 
the outer nuclear layer (ONL), the outer plexiform layer (OPL), the inner nuclear layer (INL), 
the inner plexiform layer (IPL) and the gangliar layer (G). In green (upper right panel), the 
tubulin labeling displays the fiber layer (FL), where axons of retinal ganglion cells (RGCs) are 
located, parallel to the gangliar layer, and RGCs dendrites in the IPL. CLIC1 staining, in red 
(bottom left), showed that CLIC1 was expressed in the mouse retina, and it was mainly 
expressed in the cell bodies of the RGCs, in the gangliar layer, which is more evident in the 
inset, and in the IPL and OPL, where dendrites of RGCs and neurites of bipolar neurons and 
photoreceptors lay, respectively. On the bottom right panel is shown the merge.  
Once we assessed CLIC1 expression in mammalian retina, we asked whether its expression 
could be affected in the neurodegenerative process affecting RGCs in AD patients. 
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Figure 1. 
Immunohistochemistry of a mouse retina. In the upper left panel nuclei labeling with 
DAPI (blue) identifies the gangliar layer (GL), inner plexiform layer (IPL), inner nuclear 
layer (INL), outer plexiform layer (OPL), and outer nuclear layer (ONL). In the upper 
right panel the tubulin staining (green); in the bottom left panel in red is shown CLIC1. 
The inset depicts an enlargement of CLIC1 staining in the GL. The bottom right panel 
shows the merge of all panels.  
 
Our hypothesis was also reinforced by previous studies linking CLIC1 functional expression 
with neurodegeneration in the CNS, in AD pathogenesis (Milton et al., 2008;Novarino et al., 
2004). Thus, we analyzed CLIC1 expression in the retina tissue of AD mouse models. AD 
mouse models have been widely used in biomedical research. Thus, many different genetically 
engineered mice have been developed. TgCRND8 encode a double-mutant form of amyloid 
68 
 
precursor protein (APP) under the control of the Prion Protein gene promoter (Chishti et al. 
2001). 
 
 
Figure 2. 
Immunohistochemistry on retina slices from TgCRND8 mice  (B, D, F) and their control 
littermates (A, C, E) at 1 month (A, B), 5 months (C, D) and 10 months (E, F) of age. 
CLIC1 staining (red) increased with age mainly in  TgCRND8 mouse model. DAPI (in 
blue) labeled nuclei allowing to distinguish the gangliar layer and the inner nuclear 
layer, while lectin (in green) labels blood vessels. Scale bar 10 µm. 
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These mice show Aβ deposits, and the first cognitive symptoms resulting in impaired 
performances at the water maze test, at 3 months of age, even though they do not show 
neurofibrillary tangles. Left panels of figure 2 depict immunostaining of retina slices from 
control non transgenic mice with the C3H/B6 background, while on the right there are images of 
retinas from the TgCRND8 mice, at the different ages indicated: from the top to the bottom at 1, 
5 and 10 months of age respectively. We can clearly see that in AD retinas there is a slight 
increase of CLIC1 expression (red) in the retinal ganglion cells layer already at 1 month of age, 
which means much before the manifestation of the first disease symptoms. At 5 and 10 months 
of age CLIC1 expression is visibly increased also in the IPL. The lectin staining, in green, 
highlights the absence of activated microglia, but labels the blood vessels. 
In order to confirm these results, we analyzed CLIC1 expression in a different AD mouse model, 
the 3xTg. This model was developed by LaFerla and colleagues few years ago. This model 
carries three mutations in the APP gene, in Tau gene and in Presenilin gene. The three mutations 
cause the deposition of amyloid beta (Aβ) aggregates in the CNS, neurofibrillary tangles, and 
defects in the mechanism of long term potentiation (LTP) (Oddo et al., 2003). 
Differently from the TgCRND8 model, these mice develop the first memory deficits, and show 
amyloid plaques around 6 months of age. Figure 3 depicts an image of mouse retinas from 3xTg 
mice (on the right) and their age-matched control littermates (carrying the mutation in the PS1 
gene, on the left), stained for CLIC1 (red). From the top to the bottom there are retinas from 
animals at 5, 10 and 17 months of age. We can clearly see that in AD models there was an 
increased CLIC1 (red) expression compared to their control littermates, that was already visible 
in 5 months old mice and increased with aging. Although there was a slight increase of CLIC1 
expression also in control mice, the enhancement was higher in 3xTg mice. There was a broad 
increase of CLIC1 expression in the whole retina tissue, even though we can notice that this was 
more pronounced in the gangliar layer, as indicated by the white arrows. As we have mentioned 
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above, the onset of the first symptoms in these mice is around 6 months of age, so CLIC1 
expression increases before the manifestation of the first symptoms.  
 
 
Figure 3. 
 Immunohistochemistry  on retina slices from 3xTg mice (right) and their control 
littermates (left panels) at 5, 10 and 17months. CLIC1 staining increased in the retinal 
ganglion layer of tg3x mice  compared to  wt, (white arrows). Scale bars 20um. 
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Fiorentini and colleagues (ref) have previously demonstrated that TgCRND8 mice show an AD 
phenotype already at three months of age, with cognitive deficits accompanying an increased 
inflammatory state both in the hippocampus and in the cortex, underlined by microglia and 
astrocytes activation (Fiorentini et al., 2010). Thus, in order to verify whether the increased 
CLIC1 expression in the retina was actually linked to the pathological state of AD brain, we 
compared our results obtained from immunohistochemistry of TgCRND8 retina slices with those 
obtained from the hippocampus. In the upper panel of Figure 4 it is shown the staining of brain 
slices from 5 months old TgCRND8 mice with lectin (green), to label activated microglia, while 
the bottom panel depicts CLIC1 staining (red) in the retinas belonging to the same animals. We 
can see an increased number of activated microglia in TgCRND8 mouse brain (upper right) 
compared to their control wt littermates (upper left), in parallel with the increased CLIC1 
expression in the AD mouse retina (bottom right) compared to the control retinas (bottom left). 
These results further suggest that CLIC1 increase in retina is actually parallel to a pathological 
brain condition.  
To test the hypothesis of a “direct” effect of Aβ on RGCs as a causative factor of the increased 
CLIC1 expression, we stimulated dissociated RGCs cultures with Aβ.  
It has been previously demonstrated that Aβ alters the electrophysiological properties of 
neuronal membranes, affecting membrane potential and evoked action potentials (Hartley et al., 
1999).  
Thus, we performed whole cell patch clamp experiments and we measured membrane potential 
of these cells upon Aβ treatment. In the upper panel of figure 5 is shown one example of a 
membrane potential recording of a 7 DIV (days in vitro) RGC upon Aβ stimulation. Average 
resting membrane potential of these cells after 7 DIV is around -60 mV. We added growing Aβ 
72 
 
concentrations every 5 minutes, and after 20 minutes of Aβ stimulation we can clearly see a 
membrane depolarization. Membrane potential slowly changed and reached -20/-10 mV. 
 
Figure 4.  
Microglia (green) activation in the hippocampus CA1 layer is parallel with increased 
CLIC1 expression in the retina of 5 months old TgCRND8 mice. Microglia cells increase 
in number (upper panel). CLIC1 expression (red) increases  in retina of 5 months old 
TgCRND8 mice. 
 
To check for the optimal concentration of Aβ able to exert a response in RGCs, we made a dose-
response curve of Aβ concentration versus membrane potential, shown on the bottom panel of 
figure 5. In a first set of experiments, we acutely stimulated RGCs with increasing 
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concentrations of Aβ ranging from 1 nM up to 100 nM while continuously measuring the 
membrane potential.  
 
Figure 5. 
 In the upper panel the membrane potential recordings of a 7 DIV RGC upon sequential  
stimulation with growing concentrations of Aβ, from 1nM up to 100nM, as indicated in 
the x-axis. In the bottom panel the dose response curve of membrane potential obtained 
by sequentially applicating different Aβ concentrations (black squares). The red circles 
refer to the average resting membrane potential of 5 cells per each point, incubated for 
24 hours with the different Aβ concentrations indicated.  
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The membrane potential (on the y-axis) recorded at the corresponding Aβ concentration (on the 
x-axis) exerting a depolarization is reported as the black squares.  
In a different set of experiments, we incubated RGCs for 24 hours with different Aβ 
concentrations (reported on the x-axis) and measured the membrane potential of 5 cells in the 
dish. The average values of 5 cells chronically treated with Aβ is reported in the graph as red 
squares. From the comparison between the values obtained in the acute treatment and in the 
chronic treatment, we can see a comparable effect of Aβ stimulation in the two experimental 
conditions. However, while 100 nM is the maximum concentration tolerated by the cell in the 
acute treatment, after which the seal is lost, in chronic treatment we were able to stimulate the 
cells with greater Aβ concentrations, up to 400 nM. However, we did not see further changes in 
the membrane potential.  
Once we had checked for Aβ direct effect on isolated RGCs upon Aβ stimulation, in an 
environment that is free of glial contribution, we investigated Aβ stimulation effect on CLIC1 in 
isolated RGCs, in the same conditions in which we measured membrane potential changes. 
Figure 5 shows CLIC1 staining in dissociated mouse RGCs. In the bottom panel the staining 
shows CLIC1 expression after 24 hours stimulation with low concentrations of Aβ (100 nM), 
while on the upper panel we see CLIC1 expression (red) in vehicle-treated cells. However, 
differently from what we saw in whole retinas, in these conditions the increased CLIC1 
expression is not as clear as we saw in the whole retina tissue.  
The observed differences were quite unexpected. However, we need to consider two main facets: 
first of all that the effects of Aβ on CLIC1 expression in RGCs in the whole retina can be the 
result of both the direct effect of Aβ on RGCs and the additional effect of Aβ-activated glia.   
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Figure 6.  
Immunocytochemistry on dissociated RGCs. Ab oligomers (100nM; bottom panel) or 
vehicle (upper panel) were added to RGCs for 48h. CLIC1 is stained in red, Ab in 
magenta, tubulin in green and nuclei in blue (DAPI). E and L represent the merge of 
images shown in the left small panels. Scale bars 10 µm.  
 
The second important point to consider is that while the increased CLIC1 expression was seen in 
whole adult retinas (3 months old mice and older), Aβ stimulation of cultured RGCs was 
performed on young (P1 mice-derived retinas) RGCs. The age of RGCs can “make the 
difference” in the sensitivity of RGCs to Aβ.  
76 
 
We hypothesized that the changes in CLIC1 expression that we noticed in adult RGCs of AD 
mice, might be linked to CLIC1 role in RGCs physiology, thus we proceeded in further 
investigating this mechanism in “young” isolated RGCs. 
 
Figure 7. 
CLIC1 expression in isolated RGCs. Tubulin (green) and CLIC1 (red) staining in cell 
body and neurites of RGCs (A and B). In C Actin (green) and CLIC1 (red) staining shows 
CLIC1 distribution throughout the growth cones of RGCs. 
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As we have shown in figure 6, CLIC1 is expressed in the cell body of isolated RGCs. We 
analyzed in more detail CLIC1 expression in cultured RGCs.  
We isolated RGCs from retina tissue of postnatal day 1 (P1) mice. Figure 7 shows 3 (DIV) 
RGCs from P1 mice. The cell is labeled with tubulin (green, A and B) and the growth cones (C) 
are labeled with phalloidin (green), in order to visualize the complex structure of the F-actin 
cytoskeleton of the growth cone. CLIC1 staining, in red, localizes CLIC1 in the cell body, along 
the neurites and in the growth cones.  
As we observed a strong expression of CLIC1 at the growth cones of RGCs, we wondered 
whether CLIC1 can be somehow involved in axonal outgrowth. 
 
6.2 CLIC1 in axon outgrowth of retinal ganglion cells. 
When progenitor cells in the retina stop duplicating and exit the cell cycle, they migrate towards 
their final destination site. During migration they undergo a maturation process and their neurites 
differentiate either into dendrites or axons. In response to factors released by the basal lamina, 
they send out a basal process that will drive the migration and in the end will become the axon, 
and an apical process that will become the dendrite. Even though factors from the basal lamina 
are very important in this mechanism, many other intrinsic factors are crucial, such as neuronal 
excitability, ion channels, and it has been demonstrated the key role of cytoskeleton dynamics at 
the growth cones in this process (Polleux and Snider, 2010).  
Growth cones are rich in actin and previous studies have demonstrated the effect of F-actin on 
the activity of CLIC1 ion channel (Singh et al., 2007). Moreover, many studies have shown the 
interaction of other members of CLIC family with actin in kidney and brain (Berryman et al., 
2004;Suginta et al., 2001). 
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Figure 8. 
 Quantification of axon length in vehicle-treated (ctrl) and IAA94-treated cells. RGCs in 
control conditions (upper left panel) and upon IAA94 treatment (upper right panel). In 
the bottom panel is shown the histogram depicting the average axon length of RGCs 
neurites from 3 different experiments. The number of  neurons analyzed is indicated on 
the top of each column.  Data are presented as mean values ± s.e.m. Student t-test 
p<0.05. 
 
We isolated RGCs from P1 mice and after 30 minutes from plating they were treated with 50 µM 
IAA94, which is a widely used inhibitor of CLIC1-mediated current (Novarino et al., 2004). 
After 24 hours we measured the axon length. On the upper left panel of Figure 8 there is an 
example of a control cell after 24 hours from plating, while on the upper right panel is shown a 
cell after IAA94 treatment. From the images it is noticeable a marked reduction of the axonal 
length after IAA94 treatment. The histogram (bottom panel) depicts the axon length 
quantification of one representative experiment. We can see that upon IAA94 treatment there is a 
60% reduction in axon length (t-student test, p <0.05).  
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In order to investigate the specific involvement of CLIC1-mediated current, we incubated P1 
mice-derived RGCs with an antibody specifically directed against the N-terminus domain of 
CLIC1. Previous studies have demonstrated that, once inserted into the plasma membrane, 
CLIC1 exposes its N-terminal domain on the extracellular side (Tonini et al., 2000). The binding 
of this antibody to CLIC1 causes a reduction of CLIC1-mediated current (Milton et al., 2008). 
As shown in figure 9, 24 hours incubation of RGCs with the N-terminus directed antibody (Ab) 
caused a significant reduction of axonal length compared to the control. This reduction was 
comparable to that seen upon IAA94 treatment.  
 
Figure 9.  
Axon length quantification of N-terminus directed antibody (Ab) treated RGCs. The 
histogram depicts the average axon length of RGCs neurites from 3 different experiments. 
The number of axons analyzed is indicated on the top of each column. Data are presented 
as mean values ± s.e.m. Student t-test p<0.05.  Student t-test p<0.05.  
 
These results suggest CLIC1 involvement in axon elongation of RGCs. Previous studies 
performed in microglia cells stimulated by Aβ demonstrated that CLIC1 mediated current is 
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strictly correlated to a DIDS-sensitive component (Milton et al., 2008;Novarino et al., 2004). 
DIDS is a potent inhibitor of chloride channels resident in membrane. The genetic identity of 
DIDS-sensitive channels is not clear. They are mostly identified for their electrophysiological 
properties, as a voltage dependent, outward rectifying current (Hwang et al., 2000;Jentsch et al., 
2002). Aβ stimulation of microglia cells induces a IAA94-sensitive current, which is promptly 
followed by a DIDS-sensitive component. The activation of the DIDS-sensitive component 
seems to be triggered by the activation of the IAA94-sensitive component. Indeed, stimulation 
by Aβ of microglia cells transfected with RNA interference specifically directed against CLIC1, 
elicits an almost null IAA94 sensitive current, due to the remaining endogenous CLIC1, and a 
very small DIDS-sensitive component (Milton et al., 2008). Thus we tested the involvement of 
the DIDS sensitive current in axon elongation of RGCs. 
 
Figure 10. 
 Contribution of the DIDS-sensitive current in RGCs axon outgrowth. The histogram 
depicts the average axon length of RGCs neurites from 3 different experiments. The 
number of axons analyzed is indicated on the top of each column. Data are presented as 
mean values ± s.e.m. Student t-test p<0.05.  
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The treatment of our cells with DIDS caused a marked reduction in axon length after 24 hours of 
treatment, compared to the vehicle-treated (control) cells, as it is shown in figure 10. Although 
further experiments are needed in order to establish the precise link between the DIDS-sensitive 
and the IAA94-sensitive current, to demonstrate the effective link of these two components in 
axon outgrowth, it is reasonable to hypothesize a possible interaction of these two currents in 
axon elongation of RGCs, similarly to microglia (Milton et al., 2008).  
As the growth cone is the most involved structure in axon elongation (Geraldo and Gordon-
Weeks, 2009), we investigated whether any alteration of its morphology was associated with 
reduced axon outgrowth. 
We incubated RGCs with 50 µM IAA94 and after 72 hours we analyzed the growth cones 
morphology. Figure 11 shows an example of growth cone of a RGC. In control conditions (A), it 
is clearly visible the classical fan-like morphology of a growth cone, with the tubulin rich area 
(green) surrounded by the actin rich area  
(magenta). However, upon IAA94 treatment (B), the growth cone structure appears strongly 
altered, actin seemed “collapsed” on tubulin. CLIC1 localization (red) seemed to follow the actin 
distribution. 
Actin and tubulin occupy two completely different regions of the growth cone, thus usually there 
is a very low percentage of actin/tubulin co-localization. We thus quantified the degree of 
tubulin/actin co-localization in IAA94-treated cells compared to vehicle-treated cells. The 
histogram in figure 12 shows the quantification of actin/tubulin co-localization. In IAA94-treated 
cells actin/tubulin co-localization is much higher than in control conditions, indicating a strong 
altered growth cone morphology.  
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Figure 11. 
Morphology of 4 DIV RGCs growth cones. Axon growth cones of RGCs in control 
conditions (A) and upon IAA94 treatment (B). Co-staining of Actin (magenta), CLIC1 
(red), tubulin (green). 
 
B
   
A 
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Figure 12. 
 Quantification of Tubulin/Actin  co-localization. The histogram depicts the percentage of  
Tubulin/Actin co-localization in control conditions and upon IAA94 treatment. The 
number of growth cones analyzed is indicated on the top of each column. Data are 
presented as mean values ± s.e.m. Student t-test p<0.05.  
 
Moreover, if we consider the surface covered by actin and the surface covered by tubulin at the 
growth cone and we make a ratio between the two values, in control condition the ratio actin-
covered surface (AcS) and tubulin-covered surface (TcS) is higher than 1 (Figure 13) because 
AcS is larger than TcS. On the other hand, in IAA94 treated cells the ratio AcS/TcS is almost 1, 
supporting the idea of an altered growth cone morphology.  
The different CLIC1 distribution throughout the growth cone between control and IAA94-treated 
cells, prompted us to analyze CLIC1/actin co-localization in vehicle-treated cells and in growth 
cones of IAA94-treated cells. IAA94 treatment caused a specific drastic reduction of 
CLIC1/actin co-localization (Figure 14) compared to the control, whereas, as it is shown on the 
right panel, IAA94 treatment did not affect CLIC1/tubulin co-localization.  
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Figure 13.  
Quantification of altered growth cones morphology. The histogram depicts the average 
ratio between AcS and TcS in control conditions and upon IAA94 treatment. The data are 
presented as mean values ± s.e.m. Student t-test p<0.05. The left and the right panel 
schematically show the analysis performed (see methods for details) on two growth 
cones, in control conditions (on the left) and upon IAA94 treatment (right). The number 
of growth cones analyzed is indicated on the top of each column.   
 
The treatment of the cells with IAA94 not only impaired axonal outgrowth, resulting in a 
reduced axon length and altered growth cone morphology, but it also caused an alteration of 
CLIC1/actin co-localization.  
In order to test the possibility of a direct physical interaction between CLIC1 and actin, we used 
a biochemical approach.  
CLIC family members have a high degree of homology, so first of all we tested the specificity of 
our antibody, using two different cell lines: HEK293T (human embryonic kidney) and N2a cells. 
HEK 293T are a kidney-derived cell line, while N2a are a murine neuroblastoma cell line. Panel 
A of Figure 15 shows a western blot (WB) of HEK293T cells and N2a cells transfected with 
pIRES2-EGFP. 
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Figure 14.  
Quantification of CLIC1/actin and CLIC1/tubulin co-localization. The percentage of 
CLIC1co-localization with actin (left panel) and with tubulin (right panel) in control 
conditions and in IAA94 treated cells. The number of growth cones analyzed is indicated 
on the top of each column. The data are presented as mean values ± s.e.m.  Student t-test 
p<0.05.  
 
pIRES2-EGFP is a bicistronic plasmid that allows the translation of two separate proteins: EGFP 
and CLIC1 carrying a 8-aminoacid flag at the N-terminal domain. In cell lysates belonging to 
untransfected cells (either N2a or HEK293T cells) we can see a weak band around 31 KDa 
corresponding to the endogenous CLIC1, while in transfected cells we see a higher band, 
corresponding to the overexpressed CLIC1-flag protein. On the right panel we see HEK293T 
cells transfected with pEGFP-CLIC1 that allows to express a fusion protein CLIC1-EGFP. In 
transfected cells we see a band around 54 KDa, corresponding to the fusion protein CLIC1-
EGFP, that is missing in untransfected cells. 
We then performed a biochemical assay in order to check for CLIC1/actin interaction. N2a cells 
have been treated with cytochalasin B (CytoB). This compound has been shown to interact with 
the actin cytoskeleton, causing a depolymerization of F-actin and shifting the ratio G-/F-actin 
towards G-actin (Dubinsky et al., 1999). 
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Figure 15. 
Specificity of CLIC1 antibody. (A) WB of Hek293T (on the left) and N2a (on the right) 
cells transfected with piRES2-EGFP-CLIC1, immunodecorated with anti-CLIC1 
antibody. (B) WB of Hek293T cells transfected with pEGFP-CLIC1, immunodecorated 
with anti-CLIC1 antibody. 
 
As it is shown in figure 16, N2a cells have been treated with CytoB for 60, 90 and 120 minutes. 
After each incubation time, the soluble fraction was separated from the unsoluble fraction. 
Soluble fraction is enriched in cytoplasmic proteins, including G-actin. On the other hand, the 
unsoluble fraction contains F-actin and all the cytoplasmic proteins bound to F-actin. If CLIC1 
interacts with F-actin we would find it in the unsoluble fraction, together with F-actin. More 
importantly, in CytoB-treated cells where the F-/G-actin ratio is altered, we expected a different 
CLIC1 distribution between the two fractions compared to the control. 
In the upper panel of the blot in figure 16, it is shown the distribution of actin between the two 
fractions in all the samples, as a control of the effectiveness of CytoB treatment. While in control 
cells the percentage of F- and G-actin was approximately the same, in CytoB-treated cells G-
actin (in the soluble fraction) was much more abundant than F-actin (unsoluble fraction).  
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Figure 16. 
WB analysis of cytochalasin treated N2a cells. Soluble (S) and unsoluble (U) fractions of 
lysates from N2a cells in control conditions and after cytochalasin B treatment for the 
different times indicated. In the upper panel the blot is immunodecorated with anti-actin 
antibody while the bottom panel is immunodecorated with anti-CLIC1 antibody.   
 
In the bottom panel, we see CLIC1 distribution in the different fractions. CLIC1 was not present 
in the unsoluble fraction. Moreover, CLIC1 presence in the soluble fraction did not change 
significantly following the alteration of G-/F-actin ratio due to CytoB treatment. 
Thus, even though immunocitochemistry experiments showed CLIC1 colocalization with F-
actin, these results suggest that CLIC1 and F-actin may not directly interact with each others.  
 
Membrane depolarization, by increasing neuronal excitability, has a key role in axon outgrowth. 
The depolarization that favors axon elongation is accompanied and caused itself by an increase 
of intracellular cyclic AMP (cAMP) (Goldberg et al., 2002). 
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Our cells are cultured in a Forskolin-containing medium (see methods for details). Forskolin 
enhances the axon outgrowth, by increasing cAMP and causing neuronal depolarization.   
In order to verify a possible regulative role of cAMP on CLIC1-mediated axon elongation, we 
measured axon length in IAA94-treated cells cultured in the absence of Forskolin. 
 
Figure 17.  
Quantification of axon length in RGCs cultured in Forskolin-free medium. The histogram 
depicts the average axon length of RGCs neurites from 3 different experiments. The 
number of axons analyzed is indicated on the top of each column.  Data are presented as 
mean values ± s.e.m..  
   
Figure 17 shows the results of this analysis. In this conditions, IAA94 treatment failed to induce 
any effect on axon outgrowth of RGCs. Although we can see a similar trend in the axon length 
reduction, the difference is not significant. These results suggest that probably either the 
depolarization or the direct effect of cAMP on the ion channel affects axon outgrowth.  
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    Chapter 7 
 
Discussion 
 
In 1997 Breit and colleagues were able to successfully clone  CLIC1 protein from a macrophage 
cell line (Valenzuela et al., 1997). Since then, different groups all over the world focused their 
attention on the biochemical and biophysical properties of this protein. CLIC1 unusual behavior as 
a soluble protein and as a membrane-inserted protein has attracted and fascinated many scientists 
(Averaimo et al., 2010). 
Although many concerns have been raised on the real possibility of this small protein to actually 
constitute per se a functional ion channel once inserted into the plasma membrane, growing 
evidences support the “ion channel hypothesis” (Novarino et al., 2004;Singh and Ashley, 
2006;Tonini et al., 2000;Tulk et al., 2002;Valenzuela et al., 1997;Valenzuela et al., 2000;Warton et 
al., 2002). 
Even though many studies have been performed in order to unravel its biochemical and biophysical 
properties, its physiological role has been only recently elucidated.  
CLIC1 regulation by oxidative conditions (Singh and Ashley, 2006;Tulk et al., 2002;Warton et al., 
2002) has led to suppose its involvement in many different cellular processes involving oxidation, 
such as cell proliferation, differentiation and  migration (Menon and Goswami, 2007). However, the 
most provocative physiological role has been postulated only recently, in Aβ-stimulated microglia 
cells in Alzheimer disease (AD), where it resulted to be modulated and in turn having a crucial role 
in reactive oxygen species (ROS) production by the NADPH oxidase (Milton et al., 2008;Novarino 
et al., 2004).  
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Microglia cells represent the immune system of the central nervous system (CNS) (Block et al., 
2007). The retina is part of the CNS and, given that many studies report an inflammation of this 
tissue in AD (Berisha et al., 2007), we expected to find CLIC1 expressed and functional also in the 
immune system cells of the retina. 
However, surprisingly, CLIC1 was not expressed in retinal microglia, whereas our staining 
of mouse retina sections showed its localization in the gangliar layer, where cell bodies of retinal 
ganglion cells (RGCs) are localized (Figure 1). The images showed CLIC1 expression also in the 
inner plexiform layer (IPL), where dendrites of RGCs lay and make synapses with bipolar neurons, 
and in the outer plexiform layer (OPL) where we find the synapses between bipolar neurons and 
photoreceptors, suggesting that CLIC1 expression is not limited to the cell bodies, but it can be 
diffused throughout the cell, including the neurites. This hypothesis was confirmed by 
immunocitochemical analysis on dissociated RGCs, showing CLIC1 expression all along the 
neurites. 
Even though immunohistochemistry experiments showed CLIC1 expression also in bipolar 
neurons, CLIC1 expression in the RGCs appeared us immediately quite interesting. RGCs are 
indeed the cells whose axons gather together making up the optic nerve, and many studies report 
that AD patients often complain visual deficits before the cognitive symptoms (Berisha et al., 
2007). The visual impairment has been imputed to RGCs degeneration rather than brain 
neurodegeneration in the visual cortex (Berisha et al., 2007;Guo et al., 2010), resulting in the 
thinning of the nerve fiber layer. Furthermore, LaFerla and colleagues have demonstrated the 
presence of Aβ deposits throughout the retina layers in the transgenic AD mouse model (Normando 
et al., 2009), and we have shown a cell depolarization in Aβ−stimulated cultured RGCs (Figure 5), 
testifying the toxic effect of this peptide on neuronal physiology. Thus, due to the known effects of 
Aβ on CLIC1 physiology, we wondered if in retinal neurons Aβ might have an indirect effect on 
CLIC1, as it happened in brain microglia (Milton et al., 2008;Novarino et al., 2004).  
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Our experiments clearly showed an increased CLIC1 expression in AD mouse models, both in the 
3xTg mice and in the TgCRND8 mice. It is important to keep in mind that TgCRND8 mice show 
alterations of the retina structure. Indeed, as it is noticeable in TgCRND8 mice retinas in figure 2, 
we could not see the photoreceptor layer. TgCRND8 mice, indeed, belong to the CRND8 strain, 
that often show photoreceptor degeneration (Garcia et al., 2004;Normando et al., 2009).  
However, we can be quite confident of our results for two reasons: first of all due to their 
reproducibility in a different AD model, the 3xTg. Moreover, both mouse models analyzed have 
been widely used in the biomedical research on AD and have been carefully characterized, showing 
Aβ deposits both in the brain and in the eye, and evident cognitive AD symptoms, (Fiorentini et al., 
2010;Normando et al., 2009). 
The most interesting facet to highlight is that the increased CLIC1 expression was clearly visible in 
both models before the first cognitive symptoms. In TgCRND8 mice the disease onset is around 3 
months of age (Chishti et al., 2001;Fiorentini et al., 2010), and around 6 months in the 3xTg mice 
(Oddo et al., 2003). CLIC1 expression appeared slightly increased in the gangliar layer already in 1 
month old mouse retinas in TgCRND8 and became spread throughout the IPL at 5 month of age, 
when there are the first symptoms of cognitive impairment. The lectin staining aiming at label 
microglia cells in the retina, failed to label activated microglia in the retina, suggesting that maybe 
the insult represented by Aβ deposits that have been shown in AD mouse retinas is not sufficient to 
activate microglia cells, most likely due to the main role of Muller cells as immune system cells in 
the retina. In 3xTg mice, CLIC1 expression increased already in 5 months old mice, and became 
more evident at 10 months, when it appeared also diffused throughout the other retina layers. In 
3xTg mice there was a slight increase of CLIC1 expression also in wt mice, even though it was 
much more significant in AD mice. This might be due to a subtle inflammation linked to ageing, 
that is much stronger and much more prominent in AD mice compared to the wt mice.  
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Therefore, these experiments propose CLIC1 as an early marker of neurodegeneration in AD. We 
have a protein whose expression is increased in the retina, the most accessible part of the CNS, 
before the manifestation of cognitive impairment, which means before that the neurodegenerative 
process is spread enough to severely impair the basal brain functioning. 
The research field in AD has recently shifted towards the identification of early markers of this 
disease. Indeed, one of the main problems in AD treatment is due to a late diagnosis that reduces the 
probabilities of a successful therapy. AD is usually diagnosed only after a profound cognitive 
deficit, when neuronal death is already largely diffused, rendering the actual treatments nearly 
ineffective and hampering any possibility to reverse the neurodegenerative process.  
Cordeiro’s lab  recently developed a technique that allows the visualization of RGCs apoptosis in 
vivo, by visualizing fluorescently labeled dying cells (Cordeiro et al., 2010;Guo et al., 2010). This 
technique might be an useful tool to transiently visualize fluorescently labeled-CLIC1 in AD 
patients, in order to quantify its expression in AD retina and perform an easy and early screening.  
Although we were able to clearly observe an increased expression of CLIC1 in AD mouse models, 
and we saw a direct effect of Aβ stimulation on the membrane potential of cultured RGCs, we were 
not able to detect a clear increased CLIC1 expression in isolated RGCs.  
We might explain this effect by considering the possibility of an additional contribution of Muller 
cells activation, that several studies have demonstrated in rat retinas of AD mouse models (Howlett 
et al., 2011). Muller cells activation, by releasing neurotoxic factors, might exacerbate a 
pathological state induced by Aβ, causing increased CLIC1 expression and RGCs death. Of course, 
this effect cannot be seen in pure dissociated RGC cultures.  
Furthermore, we need to consider that isolated RGCs belong to young pups, where the majority of 
RGCs are in the development stage (Wallace, 2011), while retina staining are performed on adult 
mice where RGCs are already completely mature and inserted in the complex retina circuitry.  
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Thus, the “cell age” can be a key point to explain the observed differences. 
According to this idea, we made a hypothesis that led our successive studies. A recent report 
proposes a new hypothesis for neurodegeneration in AD. It has been reported that degenerating 
neurons have increased expression of proteins specifically linked to the cell cycle, such as cyclins. 
These data led to hypothesize that the “insult” represented by Aβ can force the neuron to re-enter 
the cell cycle. However, a highly differentiated cell could not be able to successfully accomplish a 
task normally attributable to immature cells, ending up in starting an apoptosis program  (Copani et 
al., 1999).  
Thus, if we consider the hypothesis of neurodegeneration induced by Aβ as a result of the abnormal 
activation in “mature” cells of a pathway that is typical of immature cells, we can speculate that 
CLIC1 can be part of this pathway, that in the end results in cell death in Aβ-stimulated “mature” 
neurons. However, the activation of this pathway would be physiological and “successful” in 
immature cells. Thus, we hypothesized a “double” role of CLIC1, not only in RGCs pathology, but 
also in RGCs physiology, and we proceeded by investigating its role in RGCs physiology.  
Unfortunately, due to technical limitations we were not able to register CLIC1 mediated current in 
isolated RGCs. Indeed, after few hours after plating, RGCs send out neuritis that quickly become 
very long. Although this did not represent a problem for membrane potential recordings, it 
prevented us from measuring ion current, due to the incapability of successfully clamping the 
voltage in order to measure the current, on such a large surface (Armstrong and Gilly, 1992).  
Thus, in order to analyze CLIC1 functional expression in RGCs, we took advantage of an 
escamotage, by inhibiting CLIC1-mediated current with IAA94 and analyzing the subsequent 
“macroscopic” effects on maturing cells.  
We focused on axon elongation for two main reasons. First of all, while at the beginning CLIC1 
was identified in transfected cells mainly in the nucleoplasm and in the nuclear membrane, later, it 
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has been demonstrated that its subcellular localization varies strongly amongst the different cell 
types. In non-polarized cells it appears diffused throughout the cytoplasm, whereas in polarized 
cells its localization results to be also polarized (Ulmasov et al., 2007). Like all neurons, RGCs are 
highly polarized cells. RGCs progenitors, in the early postnatal phases, already have an apico-basal 
orientation which is maintained during the neuronal maturation process. Once exited the cell cycle, 
they send out a leading process that guides the migration from the retinal pigmented epithelium 
towards the vitreal surface (Barnes and Polleux, 2009). The leading process responds to different 
external cues in the maturation process. Growth cones are the most distal part of the growing axon, 
belonging to the basal region of the progenitor cell. During migration they encounter many different 
environmental cues, they interact with different regions of the extracellular matrix, responding by 
undergoing deep changes in their structure (Dent et al., 2011). Thus, due to the specific CLIC1 
subcellular localization in polarized cells, it was likely to hypothesize a role of CLIC1 in the axonal 
growth or axonal specification. Although it is worth to mention that in the cell line analyzed by 
Ulmasov and colleagues CLIC1 seems to be mostly expressed in the apical region of the cell, just 
underneath the plasma membrane, whereas the growth cones belong to the basal region of the 
progenitor cells differentiating into neurons, we need to keep in mind that Ulmasov analyzed a cell 
line belonging to the colorectal cancer and the different apical versus basal distribution of CLIC1 
can vary amongst the different polarized cell types, according to a different function in the different 
cell types (Ulmasov et al., 2007).  
The second reason concerns our staining on dissociated RGCs that showed a strong CLIC1 
expression at the growth cones that, as we mentioned before, guide axon outgrowth, further 
supporting the idea of CLIC1 role in axon outgrowth of RGCs. Our hypotheses on CLIC1 role in 
axon outgrowth due to the strong expression in the growth cones is supported by strong additional 
considerations: growth cones are highly dynamic structures, with a complex and organized 
cytoskeletal structure, rich in actin (Geraldo and Gordon-Weeks, 2009), and many studies have 
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demonstrated the interaction of actin with other members of the CLIC family. Biochemical assays 
demonstrated that CLIC4 indirectly interacts with the actin cytoskeleton (Suginta et al., 2001), and 
CLIC5 was first identified as a protein associated with the actin cytoskeleton of placental microvilli 
(Berryman and Bretscher, 2000). Furthermore, in vitro studies have shown an interaction of actin 
with CLIC1, unraveling a contribution in the modulation of the ion channel activity. Indeed, Singh 
and colleagues showed that in artificial bilayer the F-actin cytoskeleton specifically reduces CLIC1 
ion channel activity by interacting from the intracellular side, while the induction of actin 
depolymerization provides a complete recovery of ion channel functionality (Singh et al., 2007). 
Although we cannot rule out the possibility of an indirect effect of F-actin on CLIC1 due to 
membrane deformation, as so far nothing is known about the presence of actin-binding sites in 
CLIC1, it was likely to hypothesize a direct effect of actin on CLIC1.  
Our immunocitochemistry experiments on dissociated RGCs showed that the most part of 
IAA94-treated growth cones have a deeply altered morphology: they result to be “collapsed”. 
Active growth cones have a well defined fan-shaped morphology, with a central tubulin-rich area 
surrounded by an actin-rich area (Geraldo and Gordon-Weeks, 2009). IAA94-treated cells have a 
high co-localization degree of tubulin and actin. This would be in line with previous data in 
literature linking a reduced axon outgrowth with collapsed growth cones (Davis et al., 2009). 
Bradke and Dotti in 1997 demonstrated that an high dynamics of the cytoskeleton at the growth 
cone is crucial for an efficient axon elongation. Indeed they showed that in hippocampal neurons an 
increased dynamics of the actin cytoskeleton by locally increasing actin depolymerization could per 
se be sufficient to promote axon differentiation over dendrite differentiation, leading to a fast axon 
elongation (Bradke and Dotti, 1997). Actin dynamics is important as well as local actin translation 
at the growth cones (Rossoll et al., 2003). It is possible that CLIC1-mediated current could 
somehow reduce the actin dynamics causing an aberrant “stabilization” of the actin cytoskeleton, 
thus resulting in collapsed growth cones and reduced axon outgrowth. Neuron excitability has been 
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demonstrated to be also very important in axon elongation (Goldberg et al., 2002), most likely 
resulting in changes in intracellular calcium concentration due to the activation of voltage gated 
calcium channels. Increased calcium concentration could alter actin filaments structure, by affecting 
the interaction amongst the different subunits, resulting into an altered actin dynamics and reduced 
axonal outgrowth. CLIC1-mediated current can be part of this mechanism, by affecting membrane 
potential and thus neuronal excitability.  
The collapsed morphology of the growth cones in IAA94-treated cells is parallel with a 
significantly reduced co-localization between F-actin, specifically labeled with phalloidin, and 
CLIC1. This can be also explainable as a consequence of a reduction in F-actin compared to G-
actin. The altered ratio between F-actin and G-actin might cause an altered growth cones 
morphology and can be parallel to a reduced axon growth. We cannot rule out the possibility of a 
reduced CLIC1/F-actin co-localization due to an increased interaction of CLIC1 with the 
monomeric G-actin. We can also speculate that an interaction between CLIC1 and G-actin could 
lead to a sequestration of G-actin, preventing the polymerization into F-actin filaments and thus 
resulting into reduced axon length due to altered dynamics of actin cytoskeleton at the growth cone. 
Based on these results we postulated a direct interaction of CLIC1 with actin. However, our 
biochemical analysis suggested that the co-localization does not reflect into a physical interaction. 
Although we expected to see an increased CLIC1 localization in the soluble fraction upon F-actin 
depolymerization with cytochalasin, we were unable to see CLIC1 re-localization between the two 
fractions upon cytochalasin treatment. Moreover, we could not see CLIC1 in the unsoluble fraction 
together with F-actin, neither in control conditions, where actin is all polymerized and thus CLIC1 
is supposed to interact with it. These results strongly suggest that although there is a clear co-
localization between the two proteins, there is not a physical interaction. However, we need to 
consider that due to technical limitations, our biochemical assay has been performed on N2a cells, 
which are a neuroblastoma cell line, very different from mature, or developing, neurons. Although 
97 
 
we hypothesized an interaction of CLIC1 and F-actin unrelated to the cell type, we cannot rule out 
that, mainly considering the unusual nature of CLIC1, this interaction can be transient and thus be 
present only in very specific times of the cell cycle or the cell differentiation, upon different stimuli. 
Thus in our specific conditions, CLIC1 may interact with F-actin specifically at the growth cones, 
maybe transiently, during axon elongation, when CLIC1 needs to be localized in the plasma 
membrane in order to exert its role as an ion channel and mediate a chloride flux crucial for the cell 
physiology.  
Although we established a role of CLIC1 current in neuronal physiology, we cannot rule out the 
possibility of an additional role of CLIC1 as a cytoplasmic protein in RGCs physiology and axonal 
maturation. Our results clearly show that CLIC1 role in axonal elongation seems more strictly 
linked to its role as an ion channel. Indeed, both IAA94 and the N-terminus directed antibody 
inhibit the ion channel activity, by reducing CLIC1-mediated chloride current without affecting its 
possible role as a soluble protein. Nevertheless, other studies need to be performed in order to 
define an eventual additional “cytoplasmic” role of CLIC1 in this process, by specifically knocking 
down CLIC1 expression.  
Previous studies performed in microglia cells showed a tight link between IAA94-sensitive 
current and the DIDS-sensitive current. Aβ stimulation of microglia cells is indeed strictly 
correlated to the presence of a CLIC1-mediated component. Indeed, in microglia cells in which 
CLIC1 expression was specifically knocked down by siRNA, Aβ stimulation not only elicits a very 
low IAA94-sensitive current,  attributable to the low levels of endogenous protein, but it also fails 
to induce a DIDS-sensitive current (Milton et al., 2008). Thus, CLIC1-mediated current was 
considered a “trigger” for chloride current mediated by other membrane resident chloride channels, 
such as the ones mediating the DIDS-sensitive current. Indeed, Jentsch and colleagues showed that 
many chloride channels are activated by increasing intracellular chloride concentrations, maybe due 
to the interaction of chloride ions with aminoacidic residues in the ionic pathway (Jentsch et al., 
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2002). Thus, the reduced axon outgrowth in DIDS-treated cells was not completely unexpected. 
However, additional studies are needed in order to define the precise link between these two 
currents.  
Our results on IAA94 inhibition of  axon outgrowth is in line with previous data in literature 
showing increased chloride concentration in immature neurons compared to mature adult neurons. 
In immature neurons, the low expression of the potassium chloride co-transporter KCC2 and the 
higher expression of NKKC1, causes a large accumulation of chloride inside the cell. Thus, 
intracellular chloride concentration results to be increased and, as a consequence, chloride current 
results to be depolarizing instead of hyperpolarizing, like is typical of mature neurons instead. 
During development KCC2 expression changes, leading to a reduction in intracellular chloride: 
chloride current results to be hyperpolarizing (Achilles et al., 2007). Many studies show that 
depolarization and increased neuronal excitability favor axon elongation (Goldberg et al., 2002). 
From our studies, and based on the current knowledge on chloride currents in developing neurons, 
we can argue that CLIC1 mediated current in our experimental conditions, is depolarizing, thus 
helping in axonal growth. The inhibition of CLIC1 mediated current by IAA94 treatment could 
cause a hyperpolarization, impairing axonal outgrowth. As we have previously seen in microglia 
cells, the IAA94-sensitive component could be promptly followed by a DIDS-sensitive component 
that can contribute in setting the membrane potential, and thus can contribute together with CLIC1 
by increasing cell excitability and consequently axonal elongation. 
The most intriguing observation derives from the comparison of the experiments performed 
with cells cultured in forskolin-free medium and in forskolin-containing medium. Indeed, it is well 
known the effect of forskolin, resulting in increased intracellular cAMP concentration (Seamon et 
al., 1981). These results suggest a possible regulation of CLIC1 by cAMP. IAA94-induced 
reduction of axon outgrowth is indeed only significant in Forskolin-stimulated cells, where 
intracellular cAMP concentration is increased. 
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Many other ion channels are modulated by cyclic nucleotides. For example, the cardiac HCN, 
responsible for the pacemaker “funny” current, has been shown to be regulated by cyclic 
nucleotides that shift their activation threshold respectively towards hyperpolarizing and 
depolarizing potentials (Wainger et al., 2001). Furthermore, many studies clearly show a regulation 
of the Ca-activated – K channels by cAMP. In these channels, cAMP increases the open probability 
of the ion channel (Meyer et al., 2002). 
Recent studies have demonstrated that Aβ stimulation of  neuroblastoma cells and neuronal cultures 
leads to the down regulation of the CREB (cAMP response element-binding protein) pathway, by 
decreasing CREB phosphorylation (Tong et al., 2001). Moreover, long term potentiation (LTP) 
deficits in Aβ-treated slices can be rescued by treating brain slices with inhibitors of cAMP 
degradating enzymes that results in increased cAMP concentrations (Puzzo et al., 2005). 
Furthermore, constitutive activation of CREB has been demonstrated in AD mouse models (Muller 
et al., 2011), suggesting an increased cAMP concentration. Thus, many evidences suggest the 
involvement of cAMP pathway in AD.  
As we discussed previously, our studies have also shown changes in CLIC1 expression in AD mice. 
Thus, according and further supporting our initial hypothesis, we can suppose that CLIC1 has a role 
in both mechanisms, in Aβ-stimulated neurodegeneration and in axon outgrowth, and we can 
conjecture that this can happen through the same molecular pathway, driven by cAMP. We can 
speculate that during RGCs neurodegeneration in AD mice the cell initiates a signaling that includes 
the activation of the molecular pathway leading to axon elongation, by increasing cAMP levels and 
involving CLIC1, in the end leading to cell death. Increased cAMP, in turn, might cause CLIC1 
increased expression and thus neurodegeneration. However, as we said, these are only speculations 
and these hypotheses need to be demonstrated. 
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The same mechanism, involving cAMP, that in young RGCs causes axonal elongation could cause 
death in adult RGCs.  
Several observations lead us to consider an interaction and a possible modulation of CLIC1 by 
cAMP. First of all, Valenzuela and colleagues in 1997, by in silico studies on CLIC1 primary 
structure, suggested the presence of a putative cAMP phosphorylation site at threonine residue 49 
(Valenzuela et al., 1997). Moreover, our data in axon outgrowth on cells cultured in forskolin-
containing medium compared to the results obtained in cells cultured in forskolin-free medium, 
strongly suggest a mechanism of CLIC1 modulation by increased cAMP concentration elicited by 
forskolin stimulation.  
Our results can be considered very promising with regards to possible future medical 
application. Adult RGCs have very low re-growth potential after optic nerve crush (Bischof et al., 
2011). In light of our results we can assume that CLIC1 could represent an useful tool in this 
mechanism, favoring axon re-growth. Many different approaches have been used in the last decade 
in order to treat many different eye diseases, ranging from glaucoma, optic neuritis, vascular 
disruption or trauma. Gene therapy is now largely diffused in the treatment of different pathological 
conditions. For example, recombinant lentiviral, adenoviral or adenovirus-associated vectors have 
been used to specifically target cells in the inner retina, in particular RGCs. For example, 
intravitreal injection of viral vectors has been proved to be very effective to introduce growth 
promoting genes like ciliary neurotrophic factor (CNTF) and increase RGCs survival and 
regeneration after optic nerve crush (Hellstrom and Harvey, 2011). Although several experiments 
are needed in order to completely elucidate this mechanism, as we have demonstrated the role of 
CLIC1 functional expression in axon outgrowth, and assuming that this can be modulated by cAMP 
as our experiments suggest, we can speculate of a possible gene therapy approach to re-increase 
CLIC1 expression in these cells and stimulate them with cAMP in order to increase their functional 
expression. 
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Moreover, many studies have shown that the CREB pathway, activated by increased cAMP 
concentrations, is implicated in adult neurogenesis (Merz et al., 2011). This can lead us to speculate 
about a role of CLIC1 in this mechanism. Although for decades has been postulated that 
neurogenesis stopped during adulthood, it is now accepted and clearly demonstrated that adult 
neurogenesis continues throughout life in specific regions of the brain, such as the subventricular 
zone and the dentate gyrus (Ming and Song, 2011). One of the main problems in this process is that, 
although many newborn neurons are born every day, only few of them are actually able to make up 
the right connections and thus survive and correctly integrate into the brain circuitry. Axon 
outgrowth is a key step in this mechanism, and we can speculate of a possible implication of 
CLIC1, eventually providing a tool to modulate this process. 
The very important point to highlight is that with these data we have shown a direct link 
between axon outgrowth, that is a crucial step in neuronal development, and CLIC1 functional 
expression that results easily controlled from the outside. Many ion channels have been used as 
pharmacological targets due to their accessibility. Indeed, voltage gated sodium channels have been 
used as pharmacological targets in ameliorating the symptoms of chronic pain (Liu and Wood, 
2011). Moreover, specific drugs interacting with ryanodine receptors have been used in clinical 
trials against heart failure (Wehrens et al., 2005). Finally, more recently, the so called “correctors” 
of cystic fibrosis transmemebrane receptors (CFTR) activity and surface expression have been used 
in order to interact with the cause of CF (Becq et al., 2011). 
On this regard, it is also very important to emphasize that CLIC1 is not a membrane-resident ion 
channel, but its expression at the plasma membrane level is transient and stimulated by different 
factors. Several studies suggest an increased CLIC1 expression at the plasma membrane only in 
stress conditions (Averaimo et al., 2010). In particular we have previously demonstrated its 
expression at the plasma membrane following oxidative stress in microglia cells; and many other 
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studies support the hypothesis of CLIC1 insertion into the plasma membrane in proliferative 
conditions (Tonini et al., 2000). 
Given that interfering with the functionality of membrane-resident ion channels might be dangerous 
for the side effects due to the knock down of physiological functions that can be key to the cellular 
physiology, we found very interesting considering the possibility of interfering with the function of 
a channel that is transiently expressed on the plasma membrane only during a specific process, 
without affecting the basal cell physiology. This seems a promising approach in order to reduce the 
side effects and to diminish the interference with main cellular processes. 
Moreover, our studies strongly suggest that even though it is plausible the presence of an additional 
cytoplasmic role of CLIC1, the axon outgrowth is strictly linked to CLIC1 expression at the plasma 
membrane and its functional expression as a chloride-selective ion channel. 
Although it would be sure interesting to explore the specific involvement of CLIC1-mediated 
current over other chloride currents in this process, exploring the link between the DIDS-sensitive 
component and the possible involvement of other ion channels, such as the NPPB-sensitive chloride 
current, many studies suggest the involvement of other ion channels in this process (Brackenbury et 
al., 2010;Greka et al., 2003;Jablonka et al., 2007;Sernagor et al., 2010). Indeed, an important 
process like axon elongation is sure finely modulated by different factors. However, again we 
highlight the involvement of CLIC1-mediated current in this mechanism, paying particular attention 
on the unique feature of being transiently expressed at the plasma membrane. 
In light of these observations it would be interesting to analyze a possible direct regulation of cAMP 
on CLIC1 insertion into the plasma membrane or the direct regulation of CLIC1 
electrophysiological properties by cAMP, like it happens in HCN channels, as a tool to modulate 
CLIC1 functional expression in this process.  
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